nicotine has been researched along with bupropion in 546 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (3.48) | 18.2507 |
| 2000's | 347 (63.55) | 29.6817 |
| 2010's | 154 (28.21) | 24.3611 |
| 2020's | 26 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Frølund, B; Jensen, AA; Krogsgaard-Larsen, P; Liljefors, T | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Croghan, IT; Dale, LC; Glover, ED; Glover, PN; Hurt, RD; Johnston, JA; Khayrallah, MA; Offord, KP; Sachs, DP; Schroeder, DR; Sullivan, CR; Sullivan, PM | 1 |
| Benowitz, NL | 3 |
| Goldstein, MG | 1 |
| Dale, LC; Hays, JT; Hurt, RD | 1 |
| Goldstein, MG; Hughes, JR; Hurt, RD; Shiffman, S | 1 |
| Farnam, CR | 1 |
| Baker, TB; Daughton, DM; Doan, K; Fiore, MC; Hughes, AR; Johnston, JA; Jorenby, DE; Leischow, SJ; Muramoto, ML; Nides, MA; Rennard, SI; Smith, SS | 1 |
| Lee, TH | 1 |
| Carroll, FI; Damaj, MI; Martin, BR; Slemmer, JE | 1 |
| Ellis, MR; Kane, KY | 1 |
| MacKenzie, TD | 1 |
| Hughes, JR | 1 |
| Jiménez Ruiz, CA | 1 |
| DeVeaugh-Geiss, J; Elash, CA; Evoniuk, G; Gnys, M; Gwaltney, CJ; Johnston, JA; Khayrallah, M; Paty, JA; Shiffman, S | 1 |
| Fiore, MC; Nielsen, K | 1 |
| Goldstein, MG; Niaura, R | 1 |
| Hilsden, RJ; Hodgins, DC; Sutherland, LR; Timmer, A | 1 |
| Tønnesen, P | 3 |
| Ahluwalia, JS; Harris, KJ; Okuyemi, KS | 1 |
| Clem, JR | 1 |
| Prochazka, AV | 1 |
| Burkley, AR; Wewers, ME | 1 |
| Rigotti, NA | 1 |
| Campbell, IA | 1 |
| Brown, RA; Davis, RL; Larkin, JC | 1 |
| Damaj, MI; Martin, BR; Slemmer, JE | 1 |
| Bootsma, GP; Heijdra, YF; van den Berkmortel, FW; van Spiegel, PI; Wollersheim, H | 1 |
| McNeill, A; Raw, M; West, R | 1 |
| Denelsky, GY; Helge, TD | 1 |
| Haustein, KO | 1 |
| Frey, O | 1 |
| Rustin, TA | 1 |
| Abourjaily, HM; Ho, K | 1 |
| Coleman, T; West, R | 1 |
| Gattone, M | 1 |
| Giambanco, V; Lantz, MS | 1 |
| Donahue, R; Fiore, MC; Garrett, P; Jamerson, BD; Johnston, JA; Jorenby, DE; Leischow, SJ; Nides, M; Rennard, SI | 1 |
| Coleman, T | 1 |
| Alesci, NL; Boyle, RG; Davidson, G; Link Carlson, C; Magnan, S; Solberg, LI | 1 |
| Vainio, H; Weiderpass, E | 1 |
| McEwen, A; Owen, L; West, R | 2 |
| Ahluwalia, JS; Okuyemi, KS; Wadland, WC | 1 |
| Baska, T; Kavcova, E; Madar, R; Straka, S | 1 |
| Hurt, RD | 1 |
| Garrett, BE; Henningfield, JE; Rose, CA | 1 |
| Balfour, DJ | 1 |
| Obe, GF | 1 |
| Jones, DL; Mobley, CC | 1 |
| Maharaj, K; Ternullo, S | 1 |
| Corelli, RL; Hudmon, KS | 2 |
| Christensen, HR; Døssing, M; Pedersen, ST | 1 |
| Slagle, M | 1 |
| Jacobsen, CD | 1 |
| Damaj, MI; Lavecchia, KL; Martin, BR; Wiley, JL | 1 |
| Glennon, RA; Young, R | 1 |
| Ferry, LH | 1 |
| Morgan, LC; Peters, MJ | 1 |
| Taeron, C | 1 |
| Jorenby, D | 1 |
| Aubin, HJ | 1 |
| Sutherland, G | 1 |
| Gatt, ME; Heyman, SN | 1 |
| DeGraff, AC | 1 |
| Dwoskin, LP; Miller, DK; Sumithran, SP | 1 |
| Budenholzer, B | 1 |
| Lillington, GA; Sarinas, PS; Vaszar, LT | 1 |
| Aveyard, PN; Barton, PM; Forbes, CA; Hyde, CJ; Jones, L; Mather, LC; Raftery, JP; Song, FJ; Sowden, AJ; Woolacott, NF | 1 |
| Fiore, MC; Sims, TH | 1 |
| Hatsukami, DK; Kotlyar, M | 1 |
| Warnakulasuriya, S | 1 |
| Anderson, N; Fales, D; McAfee, T; Ringen, K; Zbikowski, SM | 1 |
| Cornuz, J | 2 |
| Shafait, S; Shoaib, M; Sidhpura, N | 1 |
| Gold, PB; Harvey, RT; Rubey, RN | 1 |
| Addo, F; Croghan, IT; Hurt, RD; Kardinal, CG; Knost, JA; Krook, JE; Loprinzi, CL; Michalak, JC; Morton, RF; Novotny, PJ; Porter, PA; Schaefer, PL; Sloan, JA; Stella, PJ; Tirona, MT | 1 |
| Baker, TB; Fiore, MC; Jorenby, DE; Piasecki, TM; Smith, SS | 2 |
| van Schayck, CP; Wagena, EJ; Wouters, EF; Zeegers, MP | 1 |
| Batra, V; Khurana, S; Leone, FT; Patkar, AA | 1 |
| Bruijnzeel, AW; Cryan, JF; Markou, A; Skjei, KL | 1 |
| Baker, TB; Fiore, MC; Jamerson, B; Johnston, JA; Jorenby, DE; Leischow, SJ; Nides, MA; Rennard, SI; Smith, SS | 1 |
| Dale, LC; Ebbert, JO; Erwin, PJ; Montori, VM; Rowland, LC; Vickers, KS | 1 |
| Cornuz, J; Gilbert, A; Paccaud, F; Pinget, C | 1 |
| Bardo, MT; Dwoskin, LP; Neugebauer, N; Rauhut, AS | 1 |
| Kranzler, HR; Oncken, CA | 2 |
| Hider, A; Hjalmarson, A; Lebargy, F; Sweet, R; Tonstad, S; Townsend, J; Tønnesen, P; Van Spiegel, PI | 1 |
| Bruijnzeel, AW; Markou, A | 1 |
| Waring, WS | 1 |
| Bondarev, ML; Bondareva, TS; Glennon, RA; Young, R | 1 |
| Baer, JS; Davis, TM; Fitzgibbons, K; Kivlahan, DR; Malte, CA; Saxon, AJ; Sloan, KL | 1 |
| Khazaal, Y; Krenz, S; Zullino, DF | 1 |
| Bradbury, AW; Hobbs, SD | 1 |
| Percival, J | 1 |
| Gillison, F; Hajek, P; McRobbie, H | 1 |
| Doran, C; Gates, J; Mattick, RP; Shakeshaft, A; Shanahan, M | 1 |
| Burroughs, CC; Lee, RW; Long, MA; Swanson, NA | 1 |
| Marlow, SP; Stoller, JK | 1 |
| Chorost, M; Curry, S; Dacey, S; Jack, LM; Javitz, H; McAfee, T; Swan, GE | 1 |
| Britt, DM; Burkholder, GJ; David, SP; Day, A; Griffiths, SE; Hutchison, K; Johnstone, E; Murphy, M; Niaura, R; Papandonatos, GD; Shadel, WG; Stumpff, J; Walton, RT | 1 |
| Jain, A | 1 |
| Kino, H | 1 |
| Cryan, JF; Gasparini, F; Markou, A; van Heeke, G | 1 |
| Hajek, P; McRobbie, H | 1 |
| George, TP; O'Malley, SS | 1 |
| Byers, TE; Espinoza, P; Flores, ET; Levinson, AH; Pérez-Stable, EJ | 1 |
| James-Enger, K | 1 |
| Roddy, E | 2 |
| Angrill Paxeras, J; Sampablo Lauro, I | 1 |
| Bergmann, L; Herschel, M; Warncke, W | 1 |
| Baska, T; Basková, M; Mad'ar, R; Straka, S | 1 |
| Bednarek, M; Goljan-Geremek, A; Górecka, D; Nowiński, A; Puścińska, E; Zieliński, J | 1 |
| Alvarez, F; Botella-Carretero, JI; Cantarero, M; Escobar-Morreale, HF; García, G; Martín, I; Valero, AM; Varela, C | 1 |
| Fernández Pinilla, MC; Fernández-Cruz, A; Filozof, C | 1 |
| Johnston, JA; Tonstad, S | 1 |
| Achour, N; Aouina, H; Bouacha, H; Fakhfakh, R; Gharbi, L; Hsairi, M | 1 |
| Chatkin, JM; Fritscher, CC; Haggsträm, FM; Mariante de Abreu, C; Wagner, MB | 1 |
| Bennett, K; Feely, J; Heery, A; Williams, D | 1 |
| Bunge, NE; Dale, LC; Ebbert, JO; Gauvin, TR; Hurt, RD; Vickers, KS | 1 |
| Benowitz, N; Dempsey, D | 1 |
| Brandon, TH; Westmaas, JL | 1 |
| Azcuy, AM; Barker, SA; Hill, JM; Myles, ME; Nguyen, NT; Reisch, ER; Thompson, HW | 1 |
| Bagnall, AM; McIntosh, HM; Woolacott, NF | 1 |
| Dale, LC; Ebbert, JO; Erwin, PC; Montori, V; Rowland, LC; Stead, LF; Vickers, KS | 1 |
| Ammerman, S; Green, S; Hayward, C; Killen, JD; Levin, SK; Robinson, TN; Rogers, J; Samuels, D; Schatzberg, AF; Stone, C | 1 |
| Carmody, TP; Duncan, C; Hudes, ES; Simon, JA | 1 |
| Khan, N; Wardman, AE | 1 |
| Jain, M; Talwar, A; Vijayan, VK | 1 |
| Eisendrath, SJ; Hall, SM; Humfleet, GL; Meisner, MR; Prochaska, JJ; Redding, CA; Rosen, AB; Rossi, JS; Tsoh, JY | 1 |
| Górecka, D | 1 |
| Barrueco Ferrero, M; Jiménez Ruiz, C; Palomo Cobos, L; Riesco Miranda, JA; Romero Palacios, P; Torrecilla García, M | 1 |
| Albuquerque, EX; Alkondon, M | 1 |
| Tonstad, S | 2 |
| Jepson, C; Lerman, C; Lynch, KG; Patterson, F; Perkins, K; Rukstalis, M; Strasser, A | 1 |
| Fu, SS; Geraci, MC; Hamlett-Berry, KW; Jonk, YC; Joseph, AM; Sherman, SE | 1 |
| McEwen, A; Owen, L; Raw, M; West, R | 1 |
| McLoughlin, C | 1 |
| Barrueco, M; Jiménez Ruiz, C; Palomo, L; Riesco, JA; Romero, P; Torrecilla, M | 1 |
| Andrus, MR; Roth, MT; Westman, EC | 1 |
| Colrain, IM; Swan, GE; Trinder, J | 1 |
| An, LC; Joseph, AM; Lando, H; Mohiuddin, A; Rice, K | 1 |
| Cooke, CA; Sketris, IS; Whelan, AM | 1 |
| Cosnes, J; Johnson, GJ; Mansfield, JC | 1 |
| Blumenthal, D; Pederson, LL | 1 |
| Ketterman, E; Scott, MA; Smith, KD; Smith, PO | 1 |
| Gill, GV; MacFarlane, IA; Morgan, C | 1 |
| Hébert, R | 3 |
| Dudas, MM; George, TP | 1 |
| Gur, RE; Kanes, SJ; Lerman, C; Liang, Y; Majumdar, S; Maxwell, CR; Siegel, SJ; Trief, DF | 1 |
| Breault, LG; Covington, LL; Hatfield, CH; Lutka, RW; O'Brien, JJ; Vasquez, SM | 1 |
| DiMarino, ME; Gitchell, J; McNeill, A; West, R | 1 |
| McNee, W; Metcalfe, S; Moodie, P | 1 |
| Camarelles Guillem, F | 1 |
| Eisenberg, MJ; Ludvig, J; Miner, B | 1 |
| Schroeder, SA | 1 |
| Barrett, S; Britton, J; Coleman, T; Coupland, C; Hippisley-Cox, J; Wilson, A | 1 |
| Bevins, RA; Palmatier, MI; Siebert, HL; Wilkinson, JL; Wiltgen, SM | 1 |
| O'Brien, CP | 1 |
| Berrettini, WH; Lerman, CE | 1 |
| Barrueco, M; Jiménez-Ruiz, C; Otero, MJ; Palomo, L; Riesco, JA; Romero, P; Torrecilla, M | 1 |
| Shoaib, M; Warner, C | 1 |
| Jeske, AH; Servos, TA | 1 |
| Corbridge, SJ; Wilken, L | 1 |
| Berrettini, W; Epstein, LH; Hawk, L; Jepson, C; Kaufmann, V; Lerman, C; Niaura, R; Patterson, F; Restine, S; Rukstalis, M; Wileyto, EP | 1 |
| Bernath, A; Clark, MM; Croghan, GA; Croghan, IT; Dakhil, SR; Ebbert, LP; Garneau, S; Hurt, RD; Loprinzi, CL; Morton, RF; Novotny, P; Patten, CA; Rowland, KM; Sloan, JA; Stella, PJ; Thomas, SP; Tschetter, LK; Wender, DB; Wos, EJ | 1 |
| Britt, H; Doran, CM; Mattick, RP; Robinson, M; Valenti, L | 1 |
| Bye, A; Milleri, S; Squassante, L; Teneggi, V; Tiffany, ST; Ziviani, L | 1 |
| Erwin, DS; Jennings, RE; Khambati, HN; Lake, JR; Malin, DH; Meyers-Paal, RL; Montellano, AL; Perales, BA; Presley, SE; Smith, TD | 1 |
| Lerman, C; Perkins, KA; Stitzer, M | 1 |
| Cather, C; Culhane, MA; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Green, MF; Henderson, DC; Rigotti, NA; Schoenfeld, DA | 1 |
| de Vries, H; Hoving, EF; Mudde, AN | 1 |
| Borel, ML; Guevel-Jointret, AL; Mansourati, J; Munier, S | 1 |
| Bardo, MT; Dwoskin, LP; Rauhut, AS | 1 |
| Davis, JM | 1 |
| Errard-Lalande, G | 1 |
| Ahluwalia, JS; Catley, D; Hall, M; McCool, RM; Richter, KP | 1 |
| Burke, MV; Foulds, J; Richardson, DL; Shah, P; Steinberg, MB | 1 |
| McMurry, TB | 1 |
| Foulds, J; Steinberg, MB; Williams, JM; Ziedonis, DM | 1 |
| Bouloukaki, I; Mitrouska, I; Siafakas, NM | 1 |
| Bevins, RA; Palmatier, MI; Wilkinson, JL | 1 |
| Beilby, JJ; Doran, CM; Duszynski, KM; Mattick, RP | 1 |
| Heasman, L; Heasman, PA; Nasry, HA; Preshaw, PM; Stacey, F; Swan, M | 1 |
| Bolin, K; Lindgren, B; Willers, S | 1 |
| Durkin, S; Spittal, M; Wakefield, M | 1 |
| Buffels, J; Decramer, M; Degryse, J; Heyrman, J | 1 |
| Adson, DE; al'absi, M; Brauer, LH; Bronars, CA; Candell, S; Finocchi, ME; Harris, J; Hatsukami, DK; Kotlyar, M; Robiner, W; Thuras, P | 1 |
| Andreachi, M; Appel, D; Banauch, GI; Bars, MP; Kelly, KJ; Mouren, P; Prezant, DJ | 1 |
| Aytemur Solak, Z; Başoğlu, OK; Erdinç, E | 1 |
| Durrant, R; Wakefield, M | 1 |
| Cornuz, J; Gilbert, A; McDonald, P; Paccaud, F; Pinget, C; Salto, E; Slama, K | 1 |
| Buades-Sánchez, MR; Bustamante-Navarro, R; Castillo-Aguilar, C; Contreras-Santos, C; De la Cruz-Amorós, E; Pascual-Lledó, JF | 1 |
| Cooney, J; Feinn, R; Kranzler, HR; Lando, H; Oncken, C | 1 |
| Carmody, TP; Simon, JA; Tong, EK | 1 |
| van Biljon, X | 1 |
| Meurice, JC; Paquereau, J; Underner, M | 1 |
| Borrayo, EA; Espinoza, P; Flores, ET; Levinson, AH; Pérez-Stable, EJ | 1 |
| Mooney, ME; Sofuoglu, M | 1 |
| Boyce-Smith, G; Halpin, HA; McMenamin, SB; Rideout, J | 1 |
| Chaud, MV; do Prado, JF; Ferreira-Melo, SE; Hyslop, S; Martins, LC; Moreno, H; Paganelli, MO; Sabha, M; Tanus-Santos, JE | 1 |
| Kotz, D; Wagena, EJ; Wesseling, G | 1 |
| Cofta-Woerpel, L; Wetter, DW; Wright, KL | 2 |
| James, JR; Philibin, SD; Robinson, SE; Rosecrans, JA; Vann, RE | 1 |
| An, LC; Fu, SS; Joseph, AM; Nelson, DB; Nugent, S; Partin, MR; Snyder, A; Willenbring, ML | 1 |
| Gilpin, EA; Messer, K; Pierce, JP | 1 |
| Smith, SD | 1 |
| de la Blanchardière, A; Depieds, D; Gueyffier, F | 1 |
| Adelman, WP | 1 |
| Feldman, HR; Levin, RF; Singleton, JK; Truglio-Londrigan, M | 1 |
| Shanahan, M; Shearer, J | 1 |
| Hall, S; Marteau, TM; Vogt, F | 3 |
| Hill, A | 1 |
| Dimoulas, P; Mills, EJ; Wilson, K; Wu, P | 1 |
| Lerman, C; Munafò, M | 1 |
| Siu, EC; Tyndale, RF | 1 |
| Beamonte, A; Gargallo, P; Jiménez-Muro, A; Marqueta, A; Nerín, I | 1 |
| Duquet, N | 1 |
| Ball, D; Breen, G; Guindalini, C; Neale, B; O'Gara, C; Stapleton, J; Sutherland, G | 1 |
| Bernath, A; Croghan, GA; Croghan, IT; Dakhil, SR; Ebbert, LP; Flynn, KA; Garneau, SC; Hurt, RD; Le-Lindqwister, NA; Loots, ML; Loprinzi, CL; Novotny, PJ; Rowland, KM; Sloan, JA; Tschetter, LK; Wender, DB | 1 |
| Krishnan-Sarin, S; McKee, SA; O'Malley, SS; Schepis, TS; Toll, BA | 1 |
| Ait-Daoud, N; Breland, AB; Johnson, BA; Lynch, WJ; Marzani-Nissen, GR; Penberthy, JK | 1 |
| Astray Mochales, J; Dale, LC; de Granda Orive, I; Guirao García, A; Jiménez-Ruiz, CA; Velázquez Buendía, L | 1 |
| Frishman, WH | 1 |
| Oberpichler-Schwenk, H | 1 |
| Redfern, P; Sidhpura, N; Wonnacott, S | 1 |
| Crane, R | 1 |
| Bayram, N; Dikensoy, O; Ekinci, E; Elbek, O; Filiz, A; Herken, H; Topcu, A; Uyar, M | 1 |
| Paul, CL; Turner, R; Tzelepis, F; Walsh, RA | 1 |
| Covey, LS; Fried, J; Glassman, AH; Jiang, H; LoDuca, C; Masmela, J; Petkova, E; Rodriguez, K | 1 |
| Birnbaum, A; Cather, C; Culhane, MA; Evins, AE; Freudenreich, O; Goff, DC; Henderson, DC; Horowitz, J; Hsieh, E; Rigotti, NA; Schoenfeld, DA | 1 |
| Lancaster, T; Stead, LF | 1 |
| Bertram, MY; Lim, SS; Vos, T; Wallace, AL | 1 |
| Heal, D; Redfern, P; Rowley, H; Sidhpura, N; Wonnacott, S | 1 |
| Shoaib, M; Wing, VC | 1 |
| Delnevo, CD; Steinberg, MB | 1 |
| Baker, TB; Bolt, DM; Federman, EB; Fiore, MC; McCarthy, DE; Piper, ME; Smith, SS | 1 |
| Croghan, E | 1 |
| Gould, TJ; Portugal, GS | 1 |
| Agrawal, S; Grant, KM; Kelley, SS; Meyer, JR; Romberger, DJ; Smith, LM | 1 |
| Foerster, V; Murtagh, J | 1 |
| Arabi, Z | 1 |
| Bevins, RA; Linkugel, JD; Reichel, CM | 1 |
| Caggiula, AR; Donny, EC; Liu, X; Palmatier, MI; Sved, AF | 1 |
| Lerman, C; Patterson, F; Schnoll, RA | 1 |
| Dale, LC; Ebbert, JO; Erwin, PC; Montori, V; Stead, LF; Vickers, KS | 1 |
| Doggrell, SA | 1 |
| Hoogendoorn, M; Rutten-van Mölken, MP; Welsing, P | 1 |
| Lerman, CE; Munafò, MR; Schnoll, RA | 1 |
| George, TP; Le Foll, B | 1 |
| Andrews, JO; Bennett, SM; Heath, JH | 1 |
| Cahill, K; Lancaster, T; Stead, L | 2 |
| Baker, CL; Bushmakin, AG; Cappelleri, JC; West, R | 1 |
| Allen, TM; Creeden, CL; Dudas, MM; Feingold, A; George, TP; Jatlow, PI; Potenza, MN; Sacco, KA; Vessicchio, JC; Weinberger, AH | 1 |
| David, SP; Johnstone, EC; Munafò, MR; Welton, NJ | 1 |
| Boyle, KJ; De Civita, P; Neumann, JE; Parmeter, CF; Paterson, RW | 1 |
| Cooley, ME; Murphy, M; Sarna, L; Sipples, RL | 1 |
| Ahluwalia, JS; Cox, LS; Cupertino, PA; Ellerbeck, EF; Greiner, AK; Nazir, N; Richter, KP | 1 |
| Chang, Y; Park, ER; Regan, S; Rigotti, NA | 1 |
| Argyropoulou, P; Boutou, AK; Kontou, PK; Pataka, A; Pitsiou, GG; Tsiata, EA | 1 |
| Doran, CM; Hall, WD; Lutsenko, H | 1 |
| Carrasco, C; Gómez, C; Redolat, R | 1 |
| Campbell, LA; Kisely, S | 1 |
| Benowitz, N; Epstein, LH; Hawk, LW; Lerman, C; Patterson, F; Pinto, A; Schnoll, RA; Shields, PG; Tyndale, RF; Wileyto, EP | 1 |
| Stump, AL; Wensel, TM | 1 |
| Harvey, I; Lilford, R; Song, F | 1 |
| Botello-Harbaum, M; Covey, LS; Fried, J; Glassman, AH; LoDuca, C; Masmela, J; Salzman, V | 1 |
| Crawford, JT; Goldenberg, RL; Tolosa, JE | 1 |
| Seijas, D; Tamblay, N | 1 |
| Baker, C; Boler, A; Howard, P; Knight, C | 1 |
| David, SP; Drgon, T; Johnson, C; Lerman, C; Liu, QR; Niaura, R; Rose, JE; Uhl, GR; Walther, D | 1 |
| Bölcskei, PL; Walden, K | 1 |
| Ghin, HL; Robles, GI; Singh-Franco, D | 1 |
| Hawrylak, M; Mardekian, SK; Rauhut, AS | 1 |
| Larsson, K; Nathell, L; Sundblad, BM | 1 |
| Balfour, DJ; Markou, A; Paterson, NE | 1 |
| Aldana, I; Estrada, M; Sherman, SE; York, L | 1 |
| Dworkin, SI; Stairs, DJ | 1 |
| Bélisle, P; Eisenberg, MJ; Filion, KB; Gervais, A; Joseph, L; Mottillo, S; O'Loughlin, J; Paradis, G; Pilote, L; Rinfret, S; Yavin, D | 1 |
| Cahill, K; Lancaster, T; Stead, LF | 4 |
| Chavannes, NH; Frijling, BD; Goudswaard, AN; Kaper, J; van der Laan, JR; Wiersma, T; Wind, LA | 1 |
| Oztuna, F | 1 |
| Ferguson, SG; Shiffman, S | 1 |
| Semba, J; Wakuta, M | 1 |
| Adamson, KL; Coen, KM; Corrigall, WA | 1 |
| Bader, P; McDonald, P; Selby, P | 1 |
| McKee, SA | 1 |
| Arredondo, C; Celio, M; Cromp, D; Fong, D; Fortmann, SP; Hayward, C; Killen, JD; Murphy, G; Pandurangi, M; Schatzberg, AF | 1 |
| Aydin, C; Bhatti, AS; Hall, P; Isgor, C; Ma, Z; Oztan, O; Tao, R | 1 |
| Brug, J; Knut, IK; Lemmens, V; Oenema, A | 1 |
| Hering, T | 2 |
| Schunack, W | 1 |
| Brace, V; Danielian, P; Rore, C; Williams, D | 1 |
| Alpert, JE; Culhane, MA; Evins, AE; Farabaugh, A; Fava, M; Liese, BS; Pava, J | 1 |
| Bardo, MT; Crooks, PA; Dwoskin, LP; Joyce, BM; Neugebauer, NM; Pivavarchyk, M; Zhang, Z; Zheng, G | 1 |
| Rose, JE | 1 |
| Conti, V; De Marchis, L; Girardi, E; Paone, G; Principe, R; Puglisi, G; Schmid, G; Serpilli, M | 1 |
| Covey, LS; Jiang, H; Manubay, J; Nortick, M; Palumbo, D | 1 |
| Bevins, RA; Li, C; Wilkinson, JL | 1 |
| Alcantara, LF; Bolaños-Guzmán, CA; Iñiguez, SD; Maffeo, ML; Manojlovic, Z; Parise, EM; Schuh, B; Warren, BL | 1 |
| Dima, E; Gratziou, C; Michailidou, M; Nikoloutsou, I; Roussos, C; Rovina, N | 1 |
| McEwen, A; West, R | 1 |
| Lerman, C; Ray, R; Tyndale, RF | 1 |
| Florek, E; Piekoszewski, W | 1 |
| Dent, LA; Harris, KJ; Noonan, CW | 1 |
| Brenner, H; Mann, K; Merkel, S; Reinhard, I; Salize, HJ; Twardella, D | 1 |
| Barnhart, WC; Bogen, DL; Colborn, K; Davies, ED; Lucero, CA; Moss, DR | 1 |
| Groman, E; Kunze, U; Riemerth, A | 1 |
| Arora, G; Jain, M; Talwar, A | 1 |
| Bredesen, H; Lous, J | 1 |
| Biala, G; Kruk, M | 1 |
| Bevins, RA; Carroll, FI; Wilkinson, JL | 1 |
| Alterman, A; Gariti, P; Kampman, K; Lynch, K; Varillo, K; Xie, H | 1 |
| Ahluwalia, JS; Cox, LS; Cupertino, AP; Ellerbeck, EF; Greiner, KA; Mahnken, JD; Mussulman, LM; Nazir, N; Resnicow, K; Shireman, TI | 1 |
| Bover, MT; Carson, JL; Foulds, J; Greenhaus, S; Hoover, DR; Schmelzer, AC; Steinberg, MB | 1 |
| Ferguson, SG; Gritz, ER; Henningfield, JE; Shiffman, S | 1 |
| Hall, SM; Humfleet, GL; Muñoz, RF; Prochaska, JJ; Reus, VI; Robbins, JA | 1 |
| Carmody, TP; Duncan, C; Huggins, J; Simon, JA; Solkowitz, S | 1 |
| Cryan, JF; Flynn, RA; Glynn, DA; Kennedy, MP; Kent, P | 1 |
| Laniado-Laborín, R | 2 |
| George, TP; Lising-Enriquez, K | 1 |
| Bau, CH; Bizarro, L; Dobler, CJ; Kortmann, GL | 1 |
| Heimlich, L; Steinberg, ML; Williams, JM | 1 |
| Escobar-Chávez, JJ; Ganem-Quintanar, A; López-Cervantes, M; Merino, V; Quintanar-Guerrero, D; Rodríguez-Cruz, IM | 1 |
| Deissenrieder, F; Groneberg, D; Kusma, B; Mache, S; Quarcoo, D; Welte, T | 1 |
| Cornuz, J; Etter, JF; Huguelet, P; Perneger, TV | 1 |
| Keiding, H | 1 |
| Rao, U; Schepis, TS | 1 |
| Maritz, GS | 1 |
| Annemans, L; Bartsch, P; Marbaix, S; Nackaerts, K; Prignot, J | 1 |
| Beckham, JC; Calhoun, PS; Dedert, EA; Hamlett-Berry, KW; Moore, SD; Wilson, SM | 1 |
| Caggiula, AR; Donny, EC; Levin, ME; Mays, KL; Palmatier, MI; Sved, AF | 1 |
| Covey, LS; Duan, N; LoDuca, C; Weissman, J | 1 |
| Davies, C; Gunnell, D; Irvine, D; Martin, RM; Wise, L | 1 |
| Berlin, I | 1 |
| Hajek, P; May, S; McEwen, A; McRobbie, H; Vangeli, E; West, R | 1 |
| Baker, TB; Fiore, MC; Fraser, D; Jorenby, DE; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Cupertino, AP; Ellerbeck, EF; Mussulman, L; Nazir, N; Richter, KP; Wick, JA | 1 |
| Batra, A; Friederich, HM | 1 |
| Coca, A; Coelho, OR; Ferreira-Melo, SE; Martins, LC; Moreira, MM; Moreno Júnior, H; Quinaglia, T; Sabha, M; Yugar-Toledo, JC | 1 |
| Baker, TB; Bolt, DM; Japuntich, SJ; Piper, ME; Schlam, TR | 1 |
| Corelli, RL; Hudmon, KS; Prokhorov, AV | 1 |
| Glass, M; Kuzla, N; Langer, C; Leone, F; Martinez, E; Miyamoto, C; Ridge, JA; Schnoll, RA; Tatum, KL; Weber, DM; Wileyto, EP | 1 |
| Delucchi, KL; Hall, SM; Hendricks, PS | 1 |
| Keating, GM; Lyseng-Williamson, KA | 1 |
| Baker, TB; Bolt, DM; Cinciripini, PM; Fiore, MC; Piper, ME; Smith, SS; Wetter, DW | 1 |
| Ainamo, A; Binnie, VI; Carr, AB; Fundak, A; Koeber, A; Koerber, A; Needleman, IG; Ohrn, K; Rosseel, J | 1 |
| Ebbert, JO; Hays, JT; Hurt, RD | 1 |
| Bolt, DM; Cook, JW; Jorenby, DE; Loh, WY; Piper, ME; Schlam, TR; Smith, SS | 1 |
| Bhat, A; Crain, D | 1 |
| Banham, L; Gilbody, S | 1 |
| Blough, BE; Carroll, FI; Damaj, MI; Eaton, JB; Huang, X; Lukas, RJ; Marxer-Miller, SK; Mascarella, SW; Muresan, AZ; Navarro, HA | 1 |
| Coleman, T; Gibson, J; Huang, Y; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Porwal, M; Tsoi, DT; Webster, AC | 2 |
| Abarca, M; Cornuz, J; Gonseth, S; Madrid, C | 1 |
| Blough, BE; Carroll, FI; Damaj, MI; Grabus, SD; King, LS; Lukas, RJ; Navarro, HA; Vann, RE; Warner, JA; Wiley, JL | 1 |
| Ioannides-Demos, LL; McNeil, JJ; Piccenna, L | 1 |
| Herman, AI; Sofuoglu, M | 1 |
| Feenstra, TL; Hoogenveen, RT; Kaper, J; Rutten-van Mölken, MP; van Schayck, CP; Vemer, P | 1 |
| Ruff, P | 1 |
| Zeller, A | 1 |
| von Garnier, C | 1 |
| Chen, S; Hamlett-Berry, K; Siroka, AM; Smith, MW | 1 |
| Bover, MT; Foulds, J; Richardson, DL; Schmelzer, AC; Steinberg, MB; Williams, JM | 1 |
| Baker, TB; Cook, JW; Jorenby, DE; Piper, ME; Schlam, TR | 1 |
| Johnson, TS | 1 |
| Cesario, A; Galetta, D; Granone, P; Greenberg, DS; Margaritora, S; Russo, P; Rutella, S; Spaggiari, L; Veronesi, G | 1 |
| Ebbert, JO; Hays, JT | 1 |
| Balmford, J; Borland, R; Cummings, KM; Hammond, D | 1 |
| Huh, BY; Jeon, YJ; Kim, Y; Lee, EH; Myung, SK; Park, CH; Seo, HG | 1 |
| Weinsier, ST | 1 |
| Baker, TB; Bolt, DM; Japuntich, SJ; Leventhal, AM; Piper, ME | 1 |
| Ahluwalia, JS; Benowitz, NL; Bronars, CA; Choi, WS; Cox, LS; Faseru, B; Krebill, R; Mayo, MS; Nollen, NL; Okuyemi, KS; Salzman, GA; Snow, TS; Tyndale, RF | 1 |
| Al Rubaiy, SA; Bloom, SA; Guendisch, D; Papke, RL; Trocmé-Thibierge, C | 1 |
| Blough, BE; Carroll, FI; Damaj, MI; Eaton, JB; Huang, X; Lukas, RJ; Mascarella, SW; Muresan, AZ; Navarro, HA | 1 |
| Ebbert, J; Erwin, PJ; Montori, VM; Stead, LF | 1 |
| Baker, TB; Bolt, DM; Fiore, MC; Japuntich, SJ; Leventhal, AM; Piper, ME; Roberts, LJ | 1 |
| Acıcan, T; Akkoca Yıldız, O; Eriş Gülbay, B; Karabıyıkoğlu, G; Onen, ZP; Oztürk, A; Saryal, S; Sen, E | 1 |
| Grief, SN | 1 |
| Díaz Cerezo, S; Martí Sánchez, B; Navarro Artieda, R; Sanz De Burgoa, V; Sicras Mainar, A | 1 |
| Coleman, T; Huang, Y; Langley, TE; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Baker, TB; Bolt, DM; Cook, JW; Hefner, KR; Kaye, JT; Kim, SY; Loh, WY; Piper, ME; Schlam, TR; Sheffer, MA; Smith, SS | 1 |
| Arrabal-Fernandes, FL; Bussacos, MA; Lombardi, EM; Prado, GF; Santos, Ude P; Terra-Filho, M | 1 |
| Raupach, T; van Schayck, CP | 1 |
| Herz, L; Kahler, CW; Kalman, D; Monti, P; Mooney, M; O'Connor, K; Rodrigues, S | 1 |
| Simon, JA | 1 |
| Aubin, HJ; Karila, L; Reynaud, M | 1 |
| Langer, C; Leone, F; Martinez, E; Miyamoto, C; Schnoll, RA | 1 |
| Advani, M; Cabezas, C; Martin, C; Puente, D; Rodriguez-Blanco, T | 1 |
| Agboola, S; Coleman, T; Leonardi-Bee, J; McNeill, A; Taylor, M | 1 |
| Coleman, T; Lewis, S; McNeill, A; Szatkowski, L | 1 |
| Javitz, HS; Lerman, C; Swan, GE | 1 |
| Hoch, E; Klotsche, J; Muehlig, S; Wittchen, HU | 1 |
| Biała, G; Budzyńska, B | 1 |
| Belcon, AL | 1 |
| Marti, J | 1 |
| Acheson, S; Beckham, JC; Calhoun, PS; Dedert, EA; Hamlett-Berry, KW; Lee, S; Moore, SD; Straits-Troster, K; Wilson, SM; Zaborowski, DE | 1 |
| Baker, TB; Fiore, MC | 1 |
| Adinoff, B; Brigham, G; Ghitza, U; Green, C; Kropp, F; Lindblad, R; Sharma, G; Somoza, E; Stitzer, M; Winhusen, T; Woody, G | 1 |
| Furberg, CD; Glenmullen, J; Maltsberger, JT; Moore, TJ; Singh, S | 1 |
| Ammerman, S; Bailey, SR; Crew, EE; Killen, JD; Riske, EC; Robinson, TN | 1 |
| Schuurmans, MM; Zellweger, JP | 1 |
| Biała, G; Kruk, M; Tendera, K | 1 |
| Conti, D; Cubells, JF; Gold, AB; Lerman, C; Lori, A; Wileyto, EP | 1 |
| Etter, JF; Schneider, NG | 1 |
| Carroll, FI; Damaj, MI; Grabus, SD | 1 |
| Baker, TB; Japuntich, SJ; Jorenby, DE; Leventhal, AM; Piper, ME; Schlam, TR | 1 |
| Holloway, AC; Nicholson, CJ; Raha, S; Woynillowicz, AK | 1 |
| Anthony, JC; Behm, FM; Eaton, WW; Fisher, C; Ialongo, N; Musci, R; Rose, JE; Storr, CL; Uhl, GR; Walther, D | 1 |
| Almgren, MM; Clark, KJ; Stroman, RT; Wynn, WP | 1 |
| Baker, TB; Benowitz, NL; Bergen, AW; Conti, DV; Edlund, CK; Hall, S; Javitz, HS; Krasnow, R; Kwok, PY; Lee, W; Lerman, C; Liu, J; Michel, M; Nishita, D; Swan, GE; Tyndale, RF | 1 |
| Milnerowicz, H; Sliwińska-Mossoń, M; Zieleń, I | 1 |
| Brown, VL; Cinciripini, PM; Engelmann, JM; Karam-Hage, M; Lam, C; Minnix, JA; Robinson, JD; Versace, F; Wetter, DW | 1 |
| Fagerström, KO; Kuster, M; Meyer, A; Scherr, A; Seiffert, B; Stolz, D; Tamm, M | 1 |
| Chen, HK; Lee, SM; Wu, BJ | 1 |
| Fagerström, KO; Jiménez-Ruiz, CA | 1 |
| Baker, TB; Bierut, L; Bloom, AJ; Chen, LS; Goate, A; Hatsukami, D; Martinez, M; Piper, ME; Saccone, N; Smith, SS | 1 |
| Bandrés, F; de Lucas Ramos, P; Gómez-Gallego, F; López Martín, S; Lucia, A; Rodríguez González-Moro, JM; Santiago, C; Verde, Z | 1 |
| Checa-Andrés, MD; Esparza-Martín, N; García-Cantón, C; Guerra-Rodríguez, R; Ramírez-Puga, A; Suria-González, S | 1 |
| Eapen, S; Mills, EJ; Prochaska, JJ; Thorlund, K; Wu, P | 1 |
| David, SP | 1 |
| Gupta, T; Jain, R; Majumder, P | 1 |
| Cieślewicz, A; Jabłecka, A; Korzeniowska, K | 1 |
| Daughton, DM; Rennard, SI | 1 |
| Ebbert, JO; Elrashidi, MY | 1 |
| Delucchi, KL; Grady, ES; Hall, SM; Humfleet, GL; Muñoz, RF; Reus, VI | 1 |
| Arteaga, C; Brosky, G; Oh, P; Ranger, S; Raymond, V; Selby, P | 1 |
| Baker, TB; Fiore, MC; Smith, SS | 1 |
| Biała, G; Budzyńska, B; Kruk-Słomka, M; Michalak, A | 1 |
| Bevins, RA; Charntikov, S; deWit, NR | 1 |
| Chang, CC; Chang, HA; Chen, TY; Chu, CS; Tzeng, NS | 1 |
| Fisher, DC; Fletcher, PJ; Guy, EG; Higgins, GA | 1 |
| Goutier, W; Kloeze, M; McCreary, AC | 1 |
| Hall, BJ; Levin, ED; Rose, JE; Slade, S; Wells, C | 1 |
| Blough, B; Carroll, FI; Damaj, MI; Malcolm, E; Shoaib, M | 1 |
| Ebssa, L; McCarthy, DE; Shiffman, S; Witkiewitz, K | 1 |
| He, Y; Sun, S; Wu, L; Zeng, J | 1 |
| Benowitz, NL; Prochaska, JJ | 1 |
| Ebbert, JO; Elrashidi, MY; Stead, LF | 1 |
| Abe, TO; Gaya, PV; Pereira, AC; Pinheiro, GG; Santos, PC; Scholz, J; Silva, AP | 1 |
| Seguí Díaz, M | 1 |
| Banks, ML; Blough, BE; Smith, DA | 1 |
| Prochaska, JJ | 1 |
| Cahill, K; Fanshawe, TR; Lancaster, T; Lindson-Hawley, N; Thomas, KH | 1 |
| Abe, TO; Amorim, C; Buzo, CG; Gaya, PV; Lopes, NH; Pereira, AC; Pierri, H; Santos, PC; Scholz, J | 1 |
| Blazekovic, S; Brubaker, TR; Hitsman, B; Hole, A; Kalhan, R; Langer, C; Leone, F; Patel, J; Price, S; Schnoll, R; Veluz-Wilkins, A; Wileyto, EP | 1 |
| Barboza, JL; Hudmon, KS; Patel, P; Patel, R | 1 |
| Ban, N; Hamajima, N; Hasegawa, Y; Murohara, T; Oguri, T; Okada, Y; Sato, M; Shimadu, S | 1 |
| Bérard, A; Sheehy, O; Zhao, JP | 1 |
| Kotz, D; van der Meer, RM; van Eerd, EA; van Schayck, OC | 1 |
| Abraham, P; Balali, S; Brody, AL; Enoki, R; Garcia, LY; Hellemann, GS; Hubert, R; Kawasaki, SS; McCreary, C; Young, P; Zorick, T | 1 |
| Barrett, ST; Bevins, RA; Geary, TN; Steiner, AN | 1 |
| Begh, R; Fanshawe, TR; Farley, A; Hartmann-Boyce, J; Lancaster, T; Lindson-Hawley, N | 1 |
| Gass, JC; Germeroth, LJ; Hawk, LW; Moore, FE; Motschman, CA; Munoz, DA; Rhodes, JD; Schlienz, NJ; Tiffany, ST; Wray, JM | 1 |
| Muheim, L | 1 |
| Baker, TB; Chu, W; Cook, JW; Lanza, ST; Piper, ME | 1 |
| Baraona, LK; Daniels, JL; Lovelace, D; McDaniel, L | 1 |
| Acuña Izcaray, A; Alfageme Michavila, I; Buljubasich, D; Casas, A; Chatkin, JM; de Granda Orive, JI; Guerreros Benavides, A; Jiménez Ruiz, CA; Noé, V; Núñez-Sánchez, I; Paez Espinel, N; Palomar Lever, A; Riesco Miranda, JA; Sánchez-Angarita, E; Sansores, RH; Zabert, G | 1 |
| Bekiroglu, K; Lagoa, CM; Lanza, ST; Piper, ME; Russell, MA | 1 |
| Andrade, AG; Bhugra, D; Carvalho, CFC; Castaldelli-Maia, JM; Frallonardo, FP; Gil, F; Guimarães-Pereira, BBS; Ismael, F; Loreto, AR; Richter, KP; Ventriglio, A | 1 |
| Abdul-Kader, J; Airagnes, G; D'almeida, S; Le Faou, AL; Limosin, F | 1 |
| Bambs S, C; Cerda L, J; Corvalán B, MP; Pavié G, J; Véjar M, L; Zagolin B, M | 1 |
| Harika-Germaneau, G; Jaafari, N; Peiffer, G; Perriot, J; Underner, M | 1 |
| Aveyard, P; Coleman, T; Hajek, P; Lewis, S; Lindson, N; Munafo, M | 1 |
| Inzamam Ali, M; Menakuru, S | 1 |
| Charntikov, S; Kazan, T | 1 |
| Leischow, SJ | 1 |
| Cropsey, KL; Hugley, MJ; Nguyen, AT; Sisson, ML; Wolford-Clevenger, C | 1 |
| Hajek, P; Hartmann-Boyce, J; Jarvis, M; Livingstone-Banks, J; Norris, E; West, R | 1 |
| Gilbert, DG; Gilbert-Matuskowitz, EA; Klein, KP; Pergadia, ML; Rabinovich, NE | 1 |
| Brath, H; Fasching, P; Kaser, S; Tatschl, C | 1 |
| Brousse, G; de Chazeron, I; Harika-Germaneau, G; Jaafari, N; Peiffer, G; Perriot, J; Schmitt, A; Underner, M | 1 |
| Cornuz, J; Jacot Sadowski, I; Rat, C; Selby, K | 1 |
| Aveyard, P; Hong, B; Klemperer, E; Lindson, N; Ordóñez-Mena, JM | 1 |
| Eberg, M; Filion, KB; Platt, RW; Reynier, P | 1 |
| Barkin, CE; Blough, BE; Carroll, FI; de Moura, FB; Kohut, SJ; Mello, NK | 1 |
| Havard, A; Kennedy, D; Lee, ML; Tran, DT; Welsh, A | 1 |
| Charntikov, S; Cova, N; Kazan, T; Madore, VM; Robison, CL | 1 |
| Brennan, CH; Brock, AJ; Busch-Nentwich, EM; García-González, J; Joliffe, D; Kaprio, J; Kuan, V; Martineau, AR; Palviainen, T; Parker, MO; Riley, RJ; Stemple, DL; Sudwarts, A; Teh, MT; Walton, RT | 1 |
| Abney, LR; Adams, DW; Beaulieu, DB; Freiberg, MS; Gatskie, V; Gurwara, S; Horst, SN; King, S; Peyton, SC; Pointer, SO; Schwartz, DA; Scoville, EA; Tindle, HA; Wells, QS | 1 |
| Hand, D; Kranzler, HR; Lynch, KG; Oncken, C; Schnoll, R; Tyndale, RF; Washio, Y; Zindel, LR | 1 |
| Íbias, J; Nazarian, A | 1 |
| Firth, J; Kisely, S; Siskind, DJ; Wong, TT; Wu, BT | 1 |
| Antoniu, SA; Buculei, I; Crisan Dabija, R; Mihaltan, F; Trofor, AC | 1 |
| de Chazeron, I; Jaafari, N; Peiffer, G; Perriot, J; Ruppert, AM; Underner, M | 1 |
| Evers-Casey, S; Leone, FT | 1 |
| Barrett, ST; Bevins, RA; Finkner, AP; Huynh, YW; Moran, AE; Selleck, C; Thompson, A | 1 |
| Behm, FM; Botts, DR; Botts, TL; Rose, JE; Willette, PN | 1 |
| Abramson, MJ; Bonevski, B; George, J; Gobarani, RK; Ilomäki, J; Wood, S | 1 |
| Humair, JP; Papachristou, C | 1 |
| Carpenter, MJ; Hughes, JR; Klemperer, EM; Lindson, N; Streck, JM; Su, A; West, JC | 1 |
| Alberg, AJ; Carpenter, MJ; Froeliger, B; Jones, SK; Wallace, K; Wolf, BJ | 1 |
| Baliunas, D; Comans, T; Gartner, C; Hollingworth, SA; Pole, JD; Sullivan, C | 1 |
| Barrett, ST; Bevins, RA; Dwoskin, LP; Huynh, YW; Thompson, BM; Tracy, ME | 1 |
| Brath, H; Fasching, P; Fischer-See, S; Kaser, S; Tatschl, C | 1 |
| Fanshawe, TR; Hajizadeh, A; Hartman, L; Lindson, N; Livingstone-Banks, J; Theodoulou, A; Thomas, KH | 1 |
| Ahluwalia, JS; Cox, LS; Ellerbeck, EF; Greiner, KA; Leavens, ELS; Mayo, MS; Nollen, NL; Salzman, G; Shanks, D; Woodward, J | 1 |
| Dennis, BB; Devereaux, PJ; Fairbairn, N; Lu, C; Mbuagbaw, L; Ofori, S; Olasupo, OO | 1 |
| Davis, JM; Masclans, L; Rose, JE | 1 |
| Agrawal, S; Aveyard, P; Fanshawe, TR; Freeman, SC; Hajizadeh, A; Hartmann-Boyce, J; Lindson, N; Livingstone-Banks, J; Ordóñez-Mena, JM; Sutton, AJ; Theodoulou, A; Zhu, S | 1 |
194 review(s) available for nicotine and bupropion
| Article | Year |
|---|---|
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.
Topics: Allosteric Regulation; Amino Acid Sequence; Animals; Humans; Ligands; Mice; Mice, Knockout; Models, Molecular; Molecular Sequence Data; Nicotinic Agonists; Nicotinic Antagonists; Protein Conformation; Protein Subunits; Receptors, Nicotinic | 2005 |
Bupropion sustained release and smoking cessation.
Topics: Administration, Cutaneous; Adult; Ambulatory Care; Bupropion; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Male; Mood Disorders; Nicotine; Practice Guidelines as Topic; Self Medication; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 1998 |
Drug therapy to aid in smoking cessation. Tips on maximizing patients' chances for success.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Intranasal; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Smoking Cessation | 1998 |
Recent advances in the pharmacotherapy of smoking.
Topics: Administration, Inhalation; Administration, Intranasal; Administration, Topical; Behavior Therapy; Bupropion; Chewing Gum; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Self-Help Groups; Smoking; Smoking Cessation | 1999 |
[Therapeutic advances in breaking the tobacco habit].
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Substance Withdrawal Syndrome; Tobacco Use Cessation | 1999 |
Methods to enhance smoking cessation after myocardial infarction.
Topics: Behavior Therapy; Bupropion; Combined Modality Therapy; Humans; Myocardial Infarction; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation | 2000 |
Helping patients with Crohn's disease quit smoking.
Topics: Administration, Cutaneous; Behavior, Addictive; Bupropion; Counseling; Crohn Disease; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention | 2000 |
Smoking cessation: nicotine replacement, gums and patches.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents; Bupropion; Chewing Gum; Humans; Nicotine; Smoking Cessation | 1999 |
Pharmacotherapy of smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation; United States | 2000 |
New developments in smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents; Behavior Therapy; Bupropion; Counseling; Humans; Lung Neoplasms; Nicotine; Pamphlets; Smoking; Smoking Cessation; United States | 2000 |
Smoking cessation.
Topics: Administration, Cutaneous; Adult; Bupropion; Combined Modality Therapy; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Psychotherapy; Randomized Controlled Trials as Topic; Smoking Cessation | 2000 |
Current concepts in the management of smoking cessation: a review.
Topics: Behavior Therapy; Bupropion; Dosage Forms; Drug Interactions; Education, Continuing; Humans; Nicotine; Patient Education as Topic; Practice Guidelines as Topic; Smoking Cessation | 2000 |
Techniques for smoking cessation: what really works?
Topics: Bupropion; Drug Therapy, Combination; Family Practice; Humans; Motivation; Nicotine; Smoking; Smoking Cessation | 2001 |
Pharmacological aids for smoking cessation.
Topics: Administration, Cutaneous; Administration, Intranasal; Bupropion; Central Nervous System Stimulants; Chewing Gum; Dopamine Uptake Inhibitors; Feedback; Humans; Nebulizers and Vaporizers; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2001 |
[Pharmacologic therapy for smoking cessation].
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation | 2001 |
Smoking cessation: integrating recent advances into clinical practice.
Topics: Administration, Cutaneous; Antidepressive Agents; Bupropion; Ganglionic Stimulants; Health Education; Health Policy; Humans; Motivation; Nicotine; Nortriptyline; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; United Kingdom | 2001 |
The evaluation and treatment of tobacco use disorder.
Topics: Algorithms; Bupropion; Combined Modality Therapy; Decision Trees; Dopamine Uptake Inhibitors; Drug Costs; Evidence-Based Medicine; Family Practice; Hotlines; Humans; Information Services; Internet; Nicotine; Nicotinic Agonists; Office Visits; Patient Education as Topic; Practice Guidelines as Topic; Primary Health Care; Prognosis; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2001 |
Pharmacotherapy in smoking cessation.
Topics: Bupropion; Humans; Nicotine; Smoking Cessation | 2001 |
New medications for nicotine dependence treatment.
Topics: Administration, Cutaneous; Administration, Inhalation; Bupropion; Chewing Gum; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Mecamylamine; Nicotine; Nicotinic Antagonists; Smoking; Smoking Cessation; Tobacco Use Disorder | 1999 |
Tobacco addiction and pharmacological interventions.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Tobacco Use Cessation; Tobacco Use Disorder | 2001 |
The neurobiology of tobacco dependence: a commentary.
Topics: Bupropion; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Neurobiology; Nicotine; Nucleus Accumbens; Sensitivity and Specificity; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2002 |
Helping patients to stop smoking.
Topics: Bupropion; Controlled Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotine; Nicotinic Agonists; Smoking Cessation; Treatment Outcome | 2002 |
Using nicotine replacement therapy in treating nicotine addiction in adolescents.
Topics: Adolescent; Adolescent Behavior; Bupropion; Central Nervous System Stimulants; Dopamine Uptake Inhibitors; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices | 2001 |
Medications for smoking cessation.
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2002 |
[Treatment of nicotine addiction. Drug therapy for smoking cessation].
Topics: Administration, Inhalation; Administration, Intranasal; Antidepressive Agents, Second-Generation; Bupropion; Chewing Gum; Delayed-Action Preparations; Drug Interactions; Female; Humans; Male; Nicotine; Pregnancy; Smoking Cessation; Tablets; Tobacco Use Disorder | 2002 |
Medication update.
Topics: Bupropion; Central Nervous System Stimulants; Dopamine Uptake Inhibitors; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices | 2002 |
The pharmacotherapy of smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Chewing Gum; Contraindications; Female; Humans; Mental Disorders; Nicotine; Pregnancy; Smoking Cessation | 2002 |
Clinical efficacy of bupropion in the management of smoking cessation.
Topics: Body Weight; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Administration Schedule; Female; Humans; Male; Nicotine; Practice Guidelines as Topic; Secondary Prevention; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Tolerability and safety of sustained-release bupropion in the management of smoking cessation.
Topics: Bupropion; Clinical Trials as Topic; Consumer Product Safety; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Humans; Nicotine; Seizures; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Tobacco Use Disorder; Xerostomia | 2002 |
Current approaches to the management of smoking cessation.
Topics: Bupropion; Delayed-Action Preparations; Hotlines; Humans; Nicotine; Practice Guidelines as Topic; Psychotherapy, Group; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2002 |
Achieving tobacco cessation: current status, current problems, future possibilities.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Bupropion; Chewing Gum; Forecasting; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder; Treatment Failure | 2002 |
The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation.
Topics: Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Ganglionic Stimulants; Humans; Nicotine; Smoking Cessation; Treatment Outcome | 2002 |
Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy?
Topics: Bupropion; Clinical Trials as Topic; Drug Administration Schedule; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2002 |
Managing nicotine addiction.
Topics: Administration, Inhalation; Adolescent; Adult; Antidepressive Agents, Tricyclic; Bupropion; Chewing Gum; Clonidine; Drug Combinations; Female; Humans; Logistic Models; Nicotine; Nicotinic Agonists; Nortriptyline; Pregnancy; Smoking; Sympatholytics; Tobacco Use Cessation; Tobacco Use Disorder; United States; United States Agency for Healthcare Research and Quality; Women's Health | 2002 |
Effectiveness of tobacco counseling in the dental office.
Topics: Adolescent; Adult; Bupropion; Canada; Clinical Trials as Topic; Counseling; Dental Hygienists; Dentist-Patient Relations; Dentists; Health Policy; Humans; Nicotine; Professional Role; Reproducibility of Results; Smoking; Smoking Prevention; Tobacco Use Cessation; United Kingdom; United States | 2002 |
Smoking cessation intervention in clinical practice.
Topics: Behavior Therapy; Bupropion; Humans; Nicotine; Patient Education as Topic; Primary Health Care; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2002 |
Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.
Topics: Administration, Buccal; Administration, Intranasal; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Smoking Cessation; Tobacco Use Disorder | 2003 |
Twenty-first century tobacco use: it is not just a risk factor anymore.
Topics: Administration, Cutaneous; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder | 2003 |
Treatments for spit tobacco use: a quantitative systematic review.
Topics: Bupropion; Chewing Gum; Ganglionic Stimulants; Humans; Nicotine; Randomized Controlled Trials as Topic; Tobacco Use Disorder; Tobacco, Smokeless; Treatment Outcome; United States | 2003 |
Pharmacotherapies to enhance smoking cessation during pregnancy.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Intranasal; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Chewing Gum; Delayed-Action Preparations; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation; Smoking Prevention | 2003 |
The role of pharmacotherapy in assisting smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Dosage Forms; Drug Administration Routes; Drug Therapy, Combination; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2003 |
Smoking cessation strategies in patients with peripheral arterial disease: an evidence-based approach.
Topics: Arteriosclerosis; Bupropion; Counseling; Humans; Nicotine; Peripheral Vascular Diseases; Smoking Cessation | 2003 |
Smoking cessation.
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Nicotine; Prevalence; Respiratory Therapy; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; United States | 2003 |
Treating nicotine addiction.
Topics: Acupuncture Therapy; Administration, Cutaneous; Anti-Anxiety Agents; Bupropion; Counseling; Dopamine Uptake Inhibitors; Exercise Therapy; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2003 |
[New drug therapy of chronic obstructive pulmonary disease].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Antidepressive Agents; Antioxidants; Bronchodilator Agents; Bupropion; Cholinergic Antagonists; Disease Progression; Drug Design; Humans; Nicotine; Protease Inhibitors; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Theophylline | 2003 |
Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion.
Topics: Animals; Bupropion; Disease Models, Animal; Extinction, Psychological; Humans; Nicotine; Reinforcement Schedule; Smoking Cessation; Tobacco Use Disorder | 2003 |
Current pharmacological treatments for nicotine dependence.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2004 |
Bupropion and other non-nicotine pharmacotherapies.
Topics: Administration, Inhalation; Adrenergic alpha-Agonists; Antidepressive Agents, Second-Generation; Bupropion; Clonidine; Dopamine Uptake Inhibitors; Drug Interactions; Humans; Mecamylamine; Nicotine; Nicotinic Antagonists; Smoking Cessation | 2004 |
[Update on the treatment of tobacco dependence].
Topics: Behavior Therapy; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2004 |
Economic rewarding of smoking cessation-facilitating drugs--a comparison of over-the-counter and prescribed nicotine replacement therapy.
Topics: Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Dosage Forms; Drug Prescriptions; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation | 2004 |
Smoking cessation and weight gain.
Topics: Body Composition; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Female; Humans; Insulin Resistance; Nicotine; Obesity; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Weight Gain | 2004 |
Does bupropion have advantages over other medical therapies in the cessation of smoking?
Topics: Administration, Cutaneous; Aged; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 2004 |
[Treatment of tobacco dependence: brief and intensive clinical intervention].
Topics: Anxiety; Bupropion; Cognitive Behavioral Therapy; Depression; Dopamine Uptake Inhibitors; Ganglionic Stimulants; Health Personnel; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2004 |
Pharmacotherapy for smoking cessation during pregnancy.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Ganglionic Stimulants; Humans; Nicotine; Pregnancy; Pregnancy Complications; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder | 2004 |
Reducing risk in smokers.
Topics: Bupropion; Chewing Gum; Counseling; Dopamine Uptake Inhibitors; Humans; Lung Neoplasms; Nicotine; Risk Reduction Behavior; Smoking; Smoking Cessation; Tobacco Use Disorder | 2004 |
Interventions for smokeless tobacco use cessation.
Topics: Bupropion; Counseling; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Tobacco Use Cessation; Tobacco, Smokeless | 2004 |
Pharmacotherapy of tobacco dependence.
Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Second-Generation; Bupropion; Clonidine; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; United States | 2004 |
[Methods and cost effectiveness of nicotine abstinence].
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cost-Benefit Analysis; Humans; Nicotine; Poland; Smoking Cessation; Tobacco Use Disorder | 2004 |
The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations.
Topics: Administration, Cutaneous; Arousal; Brain; Bupropion; Circadian Rhythm; Dopamine Uptake Inhibitors; Drug Administration Routes; Electroencephalography; Ganglionic Stimulants; Heart Rate; Humans; Nicotine; Sleep Deprivation; Sleep, REM; Smoking Cessation; Sympathetic Nervous System; Tobacco Use Disorder; Vagus Nerve | 2004 |
Review article: smoking cessation as primary therapy to modify the course of Crohn's disease.
Topics: Behavior Therapy; Bupropion; Cohort Studies; Colitis, Ulcerative; Counseling; Crohn Disease; Dopamine Uptake Inhibitors; Genetic Predisposition to Disease; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Recurrence; Remote Consultation; Sex Factors; Smoking; Smoking Cessation; Telephone | 2005 |
Smoking cessation: what works in primary care settings.
Topics: Bupropion; Counseling; Education, Medical, Continuing; Evidence-Based Medicine; Guideline Adherence; Humans; Internet; Nicotine; Practice Guidelines as Topic; Primary Health Care; Smoking; Smoking Cessation; Smoking Prevention; United States | 2005 |
Clinical inquiries. What interventions can help patients stop using chewing tobacco?
Topics: Administration, Cutaneous; Behavior Therapy; Bupropion; Chewing Gum; Dopamine Uptake Inhibitors; Humans; Nicotine; Tobacco Use Cessation; Tobacco, Smokeless | 2005 |
Non-nicotine pharmacotherapies for nicotine dependence.
Topics: Antidepressive Agents; Bupropion; Clinical Trials as Topic; Drug Therapy; Humans; Nicotine; Tobacco Use Disorder | 2005 |
Smoking cessation in patients with coronary artery disease.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Atherosclerosis; Behavior Therapy; Bupropion; Carbon Monoxide; Coronary Disease; Double-Blind Method; Hemodynamics; Humans; Hypoxia; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Thrombophilia; Tobacco Use Disorder; Vasoconstriction | 2005 |
Anticraving medications for relapse prevention: a possible new class of psychoactive medications.
Topics: Alcoholism; Behavior, Addictive; Bupropion; Cocaine-Related Disorders; Disulfiram; Humans; Naltrexone; Nicotine; Psychotherapy; Psychotropic Drugs; Secondary Prevention; Substance-Related Disorders; Tobacco Use Disorder | 2005 |
Pharmacotherapy and pharmacogenetics of nicotine dependence.
Topics: Administration, Cutaneous; Administration, Intranasal; Animals; Animals, Genetically Modified; Bupropion; Clinical Trials as Topic; Disease Models, Animal; Drug Design; Genetic Predisposition to Disease; Genotype; Humans; Nicotine; Pharmacogenetics; Phenotype; Smoking Cessation; Tobacco Use Disorder; United States | 2005 |
Adverse effects of pharmacological therapy for nicotine addiction in smokers following a smoking cessation program.
Topics: Bupropion; Female; Humans; Longitudinal Studies; Male; Nicotine; Prospective Studies; Smoking Cessation; Tobacco Use Disorder | 2005 |
How does bupropion work as a smoking cessation aid?
Topics: Administration, Cutaneous; Bupropion; Dopamine; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Nicotine; Norepinephrine; Receptors, Nicotinic; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2005 |
Drug therapy for smoking cessation: evidence-based considerations for dentistry.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Nicotine; Smoking; Tobacco Use Cessation | 2005 |
Smoking cessation--part III: Pharmacotherapy of smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Nicotine; Smoking; Smoking Cessation | 2005 |
Medication screening for smoking cessation: a proposal for new methodologies.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Bupropion; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Motivation; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2006 |
[Medications in smoking cessation].
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Cannabinoid Receptor Antagonists; Cannabinoids; Central Nervous System Stimulants; Chewing Gum; Child; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Piperidines; Polymethacrylic Acids; Polyvinyls; Pyrazoles; Rimonabant; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Cessation Devices | 2005 |
[Assisting smoking cessation].
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Surveys and Questionnaires | 2005 |
Developments in pharmacotherapy for tobacco dependence: past, present and future.
Topics: Adolescent; Adult; Bupropion; Clinical Trials as Topic; Clonidine; Drug Administration Routes; Female; Humans; Male; Nicotine; Nicotinic Agonists; Nortriptyline; Pregnancy; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2006 |
Pharmacological approaches to smoking cessation.
Topics: Bupropion; Dopamine Uptake Inhibitors; Drug Therapy; Humans; Models, Psychological; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2007 |
Pharmacologic interventions for smoking cessation.
Topics: Administration, Cutaneous; Administration, Inhalation; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Critical Care; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Nurse's Role; Patient Education as Topic; Patient Selection; Phytotherapy; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Smoking Prevention; United States; United States Food and Drug Administration; Varenicline | 2006 |
Bupropion for smoking cessation: a review.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Nicotine; Secondary Prevention; Smoking; Smoking Cessation | 2006 |
[Cigarette smoking and sleep disturbance].
Topics: Arousal; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Sleep; Sleep Wake Disorders; Smoking; Smoking Cessation | 2006 |
Bupropion for the treatment of nicotine withdrawal and craving.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Nicotine; Practice Patterns, Physicians'; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
Smoking cessation 1: pharmacological treatments.
Topics: Bupropion; Clonidine; Female; Humans; Male; Nicotine; Smoking Cessation | 2006 |
Tobacco use cessation for adolescents.
Topics: Adolescent; Algorithms; Animals; Antidepressive Agents; Behavior Therapy; Bupropion; Evidence-Based Medicine; Humans; Medical History Taking; Nicotine; Practice Guidelines as Topic; Psychology, Adolescent; Rats; Smoking Cessation | 2006 |
Evidence for smoking cessation: Implications for gender-specific strategies.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Counseling; Evidence-Based Medicine; Female; Humans; Male; Nicotine; Sex Factors; Smoking Cessation | 2005 |
Cost effectiveness analysis of smoking cessation interventions.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cost-Benefit Analysis; Counseling; Health Promotion; Humans; New South Wales; Nicotine; Nicotinic Agonists; Program Evaluation; Smoking Cessation | 2006 |
A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Bupropion; Clonidine; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Health Care Costs; Humans; Nicotine; Nortriptyline; Smoking; Smoking Cessation; Texas; Tobacco Use Disorder; Treatment Outcome | 2006 |
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2006 |
Non-nicotinic therapies for smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drugs, Investigational; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
[Quit smoking is not just a matter or will].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Humans; Nicotine; Nortriptyline; Smoking Cessation; Tobacco Use Disorder | 2006 |
Smoking cessation 3: multicomponent interventions.
Topics: Behavior Therapy; Bupropion; Clonidine; Combined Modality Therapy; Humans; Motivation; Nicotine; Nortriptyline; Psychotherapy, Brief; Smoking Cessation; Tobacco Use Disorder | 2007 |
Treating smoking dependence in depressed alcoholics.
Topics: Alcoholism; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder; Fructose; Humans; Nicotine; Psychotherapy, Group; Smoking Cessation; Topiramate | 2006 |
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Topics: Administration, Cutaneous; Administration, Inhalation; Benzazepines; Bupropion; Chewing Gum; Clonidine; Coronary Artery Disease; Humans; Monoamine Oxidase Inhibitors; Nicotine; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Selective Serotonin Reuptake Inhibitors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Tobacco, Smokeless; Varenicline | 2007 |
The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician.
Topics: Age Factors; Benzazepines; Bupropion; Complementary Therapies; Dopamine Uptake Inhibitors; Dosage Forms; Humans; Nicotine; Nicotinic Agonists; Physician's Role; Primary Health Care; Quinoxalines; Referral and Consultation; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Interventions to reduce harm from continued tobacco use.
Topics: Biomarkers; Bupropion; Carbon Monoxide; Cotinine; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention | 2007 |
Smoking cessation interventions in clinical practice.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Counseling; Humans; Motivation; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Secondary Prevention; Smoking; Smoking Cessation; Tobacco Use Disorder | 2007 |
Optimizing on smoke free legislation making the most of the opportunity.
Topics: Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Services Needs and Demand; Humans; Nicotine; Nicotinic Agonists; Nurse's Role; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Public Facilities; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Social Support; United Kingdom; Varenicline | 2007 |
Treating tobacco dependence in women.
Topics: Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Lung Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline; Women's Health | 2007 |
Interventions for smokeless tobacco use cessation.
Topics: Bupropion; Chewing Gum; Counseling; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Tobacco Use Cessation; Tobacco, Smokeless | 2007 |
Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Dopamine Uptake Inhibitors; Drug Administration Routes; Drug Partial Agonism; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline | 2007 |
Genetics and smoking cessation improving outcomes in smokers at risk.
Topics: Bupropion; Controlled Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pharmacogenetics; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2007 |
Treatment of tobacco dependence: integrating recent progress into practice.
Topics: Behavior Therapy; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Health Behavior; Health Policy; Humans; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Quinoxalines; Tobacco Use Cessation; Tobacco Use Disorder; Varenicline | 2007 |
Breaking the ties of nicotine dependence.
Topics: Algorithms; Benzazepines; Bupropion; Decision Trees; Dopamine Uptake Inhibitors; Drug Costs; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Acceptance of Health Care; Patient Care Planning; Patient Education as Topic; Practice Guidelines as Topic; Prevalence; Primary Health Care; Quinoxalines; Risk Factors; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2007 |
An update on therapeutics for tobacco dependence.
Topics: Alkaloids; Anti-Anxiety Agents; Azocines; Benzazepines; Bupropion; Clinical Trials as Topic; Databases, Bibliographic; Humans; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Quinolizines; Quinoxalines; Review Literature as Topic; Rimonabant; Smoking; Smoking Cessation; Varenicline | 2008 |
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Follow-Up Studies; Humans; Middle Aged; Motivation; Multicenter Studies as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Varenicline | 2008 |
Smoking cessation and lung cancer: oncology nurses can make a difference.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Information Services; Lung Neoplasms; Nicotine; Oncology Nursing; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American; Bupropion; Cotinine; Cues; Cytochrome P-450 CYP2A6; Drug Tolerance; Genetic Predisposition to Disease; Harm Reduction; Humans; Menthol; Mixed Function Oxygenases; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Reinforcement, Psychology; Smoking; Smoking Cessation; Tobacco Use Disorder; United States; Varenicline; White People | 2008 |
Use of smoking cessation therapies in individuals with psychiatric illness : an update for prescribers.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Dopamine Uptake Inhibitors; Drug Prescriptions; Humans; Mental Disorders; Nicotine; Nortriptyline; Smoking Cessation; Tobacco Use Disorder | 2008 |
Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bias; Bupropion; Data Interpretation, Statistical; Drug Therapy; Fluoxetine; Haloperidol; Humans; Imipramine; Meta-Analysis as Topic; Nicotine; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Smoking Cessation; Treatment Outcome | 2008 |
Smoking cessation in pregnancy: why, how, and what next...
Topics: Behavior Therapy; Benzazepines; Bupropion; Counseling; Female; Humans; Nicotine; Pregnancy; Pregnancy Outcome; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2008 |
[The ABC of smoking cessation].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Humans; Hypnosis; Motivation; Nicotiana; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
Topics: Black or African American; Bupropion; Hispanic or Latino; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2008 |
Which drug to be used in smoking cessation?
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Smoking Cessation; Treatment Outcome; Varenicline | 2008 |
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2008 |
[Treatment of smoking cessation during pregnancy].
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Chewing Gum; Combined Modality Therapy; Female; Humans; Nicotine; Pregnancy; Smoking; Smoking Cessation | 2008 |
The relevance and treatment of cue-induced cravings in tobacco dependence.
Topics: Adaptation, Psychological; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cues; Extinction, Psychological; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Drugs for tobacco dependence.
Topics: Adrenergic alpha-Agonists; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
Topics: Animals; Behavior, Addictive; Benzazepines; Bupropion; Ganglionic Stimulants; Humans; Nicotine; Nicotinic Agonists; Nonprescription Drugs; Quinoxalines; Smoking; Tobacco Use Disorder; Varenicline | 2009 |
Developing human laboratory models of smoking lapse behavior for medication screening.
Topics: Alcohol Drinking; Arousal; Bupropion; Cues; Drug Evaluation, Preclinical; Humans; Models, Psychological; Motivation; Naltrexone; Nicotine; Psychotropic Drugs; Secondary Prevention; Smoking; Smoking Cessation; Smoking Prevention; Social Environment; Social Facilitation; Tobacco Use Disorder | 2009 |
Effectiveness of smoking cessation interventions among adults: a systematic review of reviews.
Topics: Adult; Algorithms; Antidepressive Agents; Behavior Therapy; Bupropion; Counseling; Humans; Nicotine; Physician-Patient Relations; Psychotherapy, Group; Self Medication; Smoking Cessation; Treatment Outcome | 2008 |
[Modern medical support for smoking cessation].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
[Not smoking, essential for healthy lungs].
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Chewing Gum; Health; Humans; Lung; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tablets; Varenicline | 2008 |
Smoking cessation in pregnancy.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Smoking Cessation; Varenicline | 2008 |
New findings on nicotine addiction and treatment.
Topics: Animals; Benzazepines; Bupropion; Humans; Mecamylamine; Motivation; Nicotine; Nicotinic Antagonists; Quinoxalines; Reward; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.
Topics: Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Bupropion; Cytochrome P-450 CYP2A6; Genetic Association Studies; Genetic Variation; Humans; Nicotine; Pharmacogenetics; Phenotype; Tobacco Use Disorder | 2009 |
[Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2008 |
A preliminary benefit-risk assessment of varenicline in smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Product Surveillance, Postmarketing; Quinoxalines; Recurrence; Risk Assessment; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2009 |
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.
Topics: Animals; Benzazepines; Bupropion; Clinical Trials as Topic; Humans; Nicotine; Quinoxalines; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2009 |
Update on smoking cessation therapies.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cost of Illness; Drug Approval; Global Health; Humans; Morbidity; Nicotine; Nicotinic Agonists; Quinoxalines; Safety; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United States; Varenicline | 2009 |
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2009 |
Pharmacogenetics of smoking cessation therapy.
Topics: Benzazepines; Bupropion; Clonidine; Genome-Wide Association Study; Humans; Nicotine; Nortriptyline; Pharmacogenetics; Quinoxalines; Smoking Cessation; Varenicline | 2010 |
Tobacco use among individuals with intellectual or developmental disabilities: a brief review.
Topics: Adult; Benzazepines; Bupropion; Counseling; Cross-Sectional Studies; Disabled Persons; Health Policy; Humans; Nicotine; Persons with Mental Disabilities; Quinoxalines; Smoking; Smoking Cessation; Tobacco Smoke Pollution; Tobacco Use Disorder; United States; Varenicline | 2009 |
The use of iontophoresis in the administration of nicotine and new non-nicotine drugs through the skin for smoking cessation.
Topics: Administration, Cutaneous; Animals; Bupropion; Dosage Forms; Drugs, Investigational; Humans; Iontophoresis; Models, Biological; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Disorder | 2009 |
Smoking cessation for adolescents: a review of pharmacological and psychosocial treatments.
Topics: Adolescent; Adult; Behavior Therapy; Bupropion; Cognitive Behavioral Therapy; Humans; Motivation; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2008 |
Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring.
Topics: Animals; Antioxidants; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Maternal-Fetal Exchange; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Respiratory System; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2009 |
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?
Topics: Animals; Benzazepines; Bupropion; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Nicotine; Pregnancy; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2009 |
Therapeutic strategies to optimize the efficacy of nicotine replacement therapies.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Combined Modality Therapy; Humans; Nicotine; Nortriptyline; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2009 |
Current approaches to pharmacotherapy for smoking cessation.
Topics: Adolescent; Adult; Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; United States; Varenicline | 2010 |
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Delayed-Action Preparations; Health Care Costs; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Prevalence; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Smoking cessation intervention: an evidence-based approach.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Directive Counseling; Drug Therapy, Combination; Evidence-Based Medicine; Global Health; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2010 |
Improving the effectiveness of tobacco use cessation (TUC).
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Chewing Gum; Counseling; Dental Offices; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Referral and Consultation; Smoking; Tobacco Use Cessation; Varenicline | 2010 |
Combination pharmacotherapy for stopping smoking: what advantages does it offer?
Topics: Animals; Bupropion; Drug Therapy, Combination; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation | 2010 |
Smoking cessation in severe mental illness: what works?
Topics: Adult; Behavior Therapy; Body Weight; Bupropion; Dopamine Uptake Inhibitors; Female; Healthcare Disparities; Humans; Male; Mental Disorders; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Schizophrenic Psychology; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder | 2010 |
Interventions for smoking cessation and reduction in individuals with schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Humans; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention | 2010 |
Smoking cessation-recent advances.
Topics: Australia; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Humans; Immunotherapy, Active; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Transdermal Patch; Treatment Outcome; United Kingdom; United States; Varenicline | 2010 |
Comparison of available treatments for tobacco addiction.
Topics: Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nortriptyline; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2010 |
[Preventive relapse treatment for tobacco cessation - is it worthwhile?].
Topics: Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Treatment Outcome; Varenicline | 2010 |
A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2010 |
Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.
Topics: Benzazepines; Bupropion; Genetic Variation; Humans; Nicotine; Protein Subunits; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2010 |
Effectiveness of pharmacologic therapy for smoking cessation in adolescent smokers: Meta-analysis of randomized controlled trials.
Topics: Adolescent; Adolescent Behavior; Bupropion; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder | 2011 |
Interventions for smokeless tobacco use cessation.
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Cessation; Tobacco, Smokeless; Varenicline | 2011 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2011 |
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
Topics: Administration, Cutaneous; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Heart Diseases; Humans; Neoplasms; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance-Related Disorders; Varenicline | 2011 |
Pharmacotherapy for smoking cessation: current advances and research topics.
Topics: Administration, Topical; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2011 |
Pharmacotherapy for smoking cessation: present and future.
Topics: Adolescent; Animals; Benzazepines; Bupropion; Delayed-Action Preparations; Female; Humans; Nicotine; Nicotinic Agonists; Pregnancy; Quinoxalines; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline | 2011 |
Clinical practice. Treating smokers in the health care setting.
Topics: Benzazepines; Bupropion; Cholinergic Agents; Counseling; Dopamine Uptake Inhibitors; Evidence-Based Medicine; Female; Humans; Middle Aged; Motivation; Nicotine; Patient Compliance; Physician-Patient Relations; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline | 2011 |
Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Topics: Adolescent; Benzazepines; Bupropion; Clinical Trials as Topic; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Patient Compliance; Prescription Drugs; Quinoxalines; Randomized Controlled Trials as Topic; Safety; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2012 |
[Smoking cessation in medical practice--new possibilities?].
Topics: Benzazepines; Bupropion; Complementary Therapies; Drugs, Investigational; General Practitioners; Humans; Nicotine; Nicotinic Agonists; Professional Practice; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2012 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2012 |
The pharmacist "toolbox" for smoking cessation: a review of methods, medicines, and novel means to help patients along the path of smoking reduction to smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Education, Pharmacy, Continuing; Humans; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Pharmacists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2012 |
[Drugs used to treat nicotine addiction].
Topics: Adult; Age Distribution; Alkaloids; Azocines; Benzazepines; Bupropion; Causality; Comorbidity; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Poland; Quinolizines; Quinoxalines; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Varenicline; Young Adult | 2012 |
Interventions for smoking cessation and reduction in individuals with schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Varenicline | 2013 |
Smoking cessation and COPD.
Topics: Benzazepines; Bupropion; Counseling; Humans; Nicotine; Nicotinic Agonists; Prevalence; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Risk Factors; Risk Reduction Behavior; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2013 |
Smoking cessation treatment for COPD smokers: the role of pharmacological interventions.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2013 |
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
Topics: Adult; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Risk Factors; Smoking; Smoking Cessation; Varenicline | 2014 |
Pharmacological intervention of nicotine dependence.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2013 |
Smoking cessation.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2014 |
Emerging drugs for the treatment of tobacco dependence: 2014 update.
Topics: Atomoxetine Hydrochloride; Benzazepines; Bupropion; Clinical Trials as Topic; Clonidine; Humans; Mecamylamine; Nicotine; Nortriptyline; Propylamines; Quinoxalines; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2014 |
Effect of Smoking Reduction Therapy on Smoking Cessation for Smokers without an Intention to Quit: An Updated Systematic Review and Meta-Analysis of Randomized Controlled.
Topics: Adult; Aged; Benzazepines; Bupropion; Female; Humans; Intention; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Varenicline | 2015 |
The Past, Present, and Future of Nicotine Addiction Therapy.
Topics: Alkaloids; Azocines; Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Health Policy; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Social Media; Text Messaging; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Interventions for smokeless tobacco use cessation.
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Randomized Controlled Trials as Topic; Tobacco Use Cessation; Tobacco, Smokeless; Varenicline | 2015 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Azepines; Azocines; Benzazepines; Bupropion; Counseling; Heterocyclic Compounds, 4 or More Rings; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline | 2016 |
An update on the pharmacotherapeutic interventions for smoking cessation.
Topics: Benzazepines; Bupropion; Drug Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2016 |
Smoking cessation for people with chronic obstructive pulmonary disease.
Topics: Adult; Behavior Therapy; Bupropion; Combined Modality Therapy; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking Cessation; Varenicline | 2016 |
Interventions to reduce harm from continued tobacco use.
Topics: Biomarkers; Bupropion; Carbon Monoxide; Cotinine; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline.
Topics: Adult; Bupropion; Clinical Trials as Topic; Female; Humans; Laboratories; Middle Aged; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Varenicline | 2016 |
Tobacco Harms, Nicotine Pharmacology, and Pharmacologic Tobacco Cessation Interventions for Women.
Topics: Bupropion; Female; Fetus; Humans; Lactation; Nicotiana; Nicotine; Pregnancy; Pregnant Women; Smoking; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2017 |
[Interventions for smoking cessation in 2018].
Topics: Bupropion; History, 21st Century; Humans; Nicotine; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2018 |
[Smoking cessation: Pharmacological strategies different from standard treatments].
Topics: Bupropion; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Cessation Agents; Standard of Care; Tobacco Use Cessation Devices; Varenicline | 2018 |
Relapse prevention interventions for smoking cessation.
Topics: Behavior Therapy; Bupropion; Chewing Gum; Female; Humans; Male; Nicotine; Nicotinic Agonists; Pregnancy; Randomized Controlled Trials as Topic; Secondary Prevention; Smoking Cessation; Smoking Cessation Agents; Smoking Prevention; Varenicline | 2019 |
[Smoking, alcohol and diabetes (Update 2019)].
Topics: Alcohol Drinking; Benzazepines; Bupropion; Diabetes Mellitus; Humans; Nicotine; Practice Guidelines as Topic; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2019 |
[Stopping and reducing smoking in patients with schizophrenia].
Topics: Bupropion; Cognitive Behavioral Therapy; Electronic Nicotine Delivery Systems; Humans; Nicotine; Reinforcement, Psychology; Schizophrenia; Smoking Cessation; Tobacco Smoking; Tobacco Use Cessation Devices; Varenicline | 2019 |
[Smoking cessation: How can we involve patients better in treatment choice?]
Topics: Bupropion; Choice Behavior; Counseling; Decision Making, Shared; Humans; Nicotine; Patient Participation; Patient Selection; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2019 |
Expanded table: some drugs for smoking cessation.
Topics: Bupropion; Chewing Gum; Humans; Nicotine; Smoking Cessation; Smoking Cessation Agents; Statistics as Topic; Tobacco Use Cessation Devices | 2019 |
Smoking reduction interventions for smoking cessation.
Topics: Bupropion; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking Cessation; Smoking Reduction; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices | 2019 |
Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Network Meta-Analysis; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Varenicline | 2020 |
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Pulmonary Disease, Chronic Obstructive; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2021 |
[Combinations of pharmacological treatments in smoking cessation. A systematic review].
Topics: Bupropion; Humans; Nicotine; Smoking; Smoking Cessation; Varenicline | 2021 |
Tobacco Use Disorder.
Topics: Behavior, Addictive; Bupropion; Combined Modality Therapy; Counseling; Drug Therapy; Electronic Nicotine Delivery Systems; Humans; Morbidity; Neurobiology; Nicotine; Nicotinic Agonists; Phenotype; Prevalence; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; United States; Varenicline | 2022 |
A systematic review and meta-analysis of interventions to induce attempts to quit tobacco among adults not ready to quit.
Topics: Adult; Bupropion; Humans; Nicotiana; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices | 2023 |
A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation.
Topics: Bupropion; Genetic Variation; Humans; Nicotine; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2022 |
Nicotine receptor partial agonists for smoking cessation.
Topics: Alkaloids; Bupropion; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Cytisine for smoking cessation: A systematic review and meta-analysis.
Topics: Adult; Alkaloids; Azocines; Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Quinolizines; Smoking Cessation; Varenicline | 2023 |
Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses.
Topics: Adult; Bupropion; Electronic Nicotine Delivery Systems; Female; Humans; Network Meta-Analysis; Nicotine; Nortriptyline; Pregnancy; Smoking Cessation; Varenicline | 2023 |
101 trial(s) available for nicotine and bupropion
| Article | Year |
|---|---|
A comparison of sustained-release bupropion and placebo for smoking cessation.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Weight Gain | 1997 |
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Weight Gain | 1999 |
The effect of bupropion on nicotine craving and withdrawal.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female; Humans; Male; Nicotine; Patient Compliance; Psychiatric Status Rating Scales; Psychomotor Performance; Sleep; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2000 |
[Antidepressive drug against nicotine. A method for smoking cessation].
Topics: Administration, Cutaneous; Bupropion; Chewing Gum; Delayed-Action Preparations; Drug Administration Schedule; Humans; Nicotine; Smoking Cessation; Weight Gain | 2000 |
Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.
Topics: Administration, Cutaneous; Adult; Bupropion; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Nicotine; Smoking Cessation; Tobacco Use Disorder; Treatment Failure; Treatment Outcome | 2001 |
Pharmacologic therapy for nicotine addiction.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Double-Blind Method; Humans; Male; Middle Aged; Nicotine; Nortriptyline; Smoking; Smoking Cessation; Tobacco Use Disorder | 2002 |
Naturalistic, self-assignment comparative trial of bupropion SR, a nicotine patch, or both for smoking cessation treatment in primary care.
Topics: Administration, Cutaneous; Aged; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Primary Health Care; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2002 |
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2003 |
Smoking withdrawal dynamics: II. Improved tests of withdrawal-relapse relations.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Recurrence; Severity of Illness Index; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome | 2003 |
Targeting smokers at increased risk for relapse: treating women and those with a history of depression.
Topics: Administration, Cutaneous; Bupropion; Depression; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Recurrence; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention | 2003 |
A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
Topics: Adult; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Weight Gain | 2003 |
Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.
Topics: Adult; Bupropion; Counseling; Diagnosis, Dual (Psychiatry); Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Ganglionic Stimulants; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Psychotherapy, Group; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2003 |
Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity.
Topics: Administration, Cutaneous; Bupropion; Chi-Square Distribution; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Nicotine; Nicotinic Agonists; Predictive Value of Tests; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2003 |
Controlled trial for smoking cessation in a Navy shipboard population using nicotine patch, sustained-release buproprion, or both.
Topics: Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Military Personnel; Naval Medicine; Nicotine; Smoking Cessation | 2003 |
Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.
Topics: Adult; Bupropion; Counseling; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Prognosis; Risk Factors; Smoking Cessation | 2003 |
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Ganglionic Stimulants; Genotype; Humans; Male; Middle Aged; Nicotine; Placebos; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement.
Topics: Adult; Bupropion; Double-Blind Method; Female; Glucose; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2004 |
[Bupropion SR for weaning from smoking in relapsed smokers: results of an open multicentre trial in Germany].
Topics: Adult; Age of Onset; Antidepressive Agents, Second-Generation; Bupropion; Female; Humans; Male; Nicotine; Smoking Cessation; Substance-Related Disorders | 2004 |
[Effect of treatment for nicotine dependence in patients with COPD].
Topics: Administration, Cutaneous; Adult; Aged; Attitude to Health; Bupropion; Delayed-Action Preparations; Disease Progression; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Poland; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2003 |
Weight gain and cardiovascular risk factors during smoking cessation with bupropion or nicotine.
Topics: Administration, Cutaneous; Adult; Aging; Blood Pressure; Bupropion; Cardiovascular Diseases; Diastole; Female; Humans; Insulin Resistance; Lipids; Male; Middle Aged; Nicotine; Nicotinic Agonists; Obesity; Risk Factors; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Thinness; Weight Gain | 2004 |
Abstinence rates and predictors of outcome for smoking cessation: do Brazilian smokers need special strategies?
Topics: Adolescent; Adult; Aged; Brazil; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Patient Acceptance of Health Care; Prospective Studies; Risk Factors; Smoking Cessation; Treatment Outcome | 2004 |
Residential treatment for smokeless tobacco use: a case series.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Combined Modality Therapy; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Pilot Projects; Residential Treatment; Tobacco Use Disorder; Tobacco, Smokeless | 2004 |
Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers.
Topics: Administration, Cutaneous; Adolescent; Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder | 2004 |
Bupropion for smoking cessation: a randomized trial.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Placebo Effect; Risk; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2004 |
Depressed smokers and stage of change: implications for treatment interventions.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Comorbidity; Depression; Female; Humans; Internal-External Control; Male; Middle Aged; Motivation; Nicotine; Personal Construct Theory; Personality Assessment; Smoking; Smoking Cessation; Treatment Outcome | 2004 |
[Continuous and momentous tobacco abstinence with pharmacologic therapy in clinical practice].
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Female; Humans; Longitudinal Studies; Male; Nicotine; Patient Compliance; Prospective Studies; Smoking; Smoking Cessation; Time Factors | 2004 |
Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm.
Topics: Adolescent; Adult; Aged; Bupropion; Choice Behavior; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Reinforcement, Psychology; Smoking Cessation; Tobacco Use Disorder | 2005 |
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
Topics: Administration, Intranasal; Adult; Alleles; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female; Genetic Variation; Genotype; Haplotypes; Humans; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Receptors, Dopamine D2; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2006 |
The prevalence of weight concerns in a smoking abstinence clinical trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Body Image; Body Weight; Bupropion; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Treatment Outcome; United States | 2006 |
Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.
Topics: Adult; Antidepressive Agents, Second-Generation; Appetite; Bupropion; Circadian Rhythm; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Nicotine; Pulmonary Gas Exchange; Saliva; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors | 2005 |
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
Topics: Adult; Attention; Bupropion; Cognition Disorders; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotine; Placebos; Psychomotor Performance; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2005 |
Predictors of smoking relapse in a sample of Dutch adult smokers; the roles of gender and action plans.
Topics: Antidepressive Agents, Second-Generation; Attitude to Health; Bupropion; Female; Humans; Intention; Male; Middle Aged; Netherlands; Nicotine; Nicotinic Agonists; Risk Factors; Secondary Prevention; Self Efficacy; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention | 2006 |
Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients.
Topics: Administration, Topical; Bupropion; Counseling; Dopamine Uptake Inhibitors; Follow-Up Studies; Humans; Interviews as Topic; Mental Health Services; Methadone; Motivation; Narcotics; Nicotine; Patient Compliance; Pilot Projects; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2005 |
Looking for boomerang effects: a pre-post experimental study of the effects of exposure of youth to television advertising for nicotine replacement therapy and Zyban.
Topics: Adolescent; Advertising; Analysis of Variance; Attitude to Health; Bupropion; Dopamine Uptake Inhibitors; Female; Hotlines; Humans; Male; Motivation; Nicotine; Psychology, Adolescent; Risk Factors; Risk-Taking; Smoking; Smoking Cessation; Social Perception; Television | 2006 |
Spirometry and smoking cessation advice in general practice: a randomised clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Airway Obstruction; Belgium; Bupropion; Child; Counseling; Dopamine Uptake Inhibitors; Family Practice; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Practice Guidelines as Topic; Smoking Cessation; Spirometry | 2006 |
"Tobacco Free With FDNY": the New York City Fire Department World Trade Center Tobacco Cessation Study.
Topics: Bupropion; Directive Counseling; Dopamine Uptake Inhibitors; Fires; Follow-Up Studies; Humans; New York City; Nicotine; Nicotinic Agonists; Rescue Work; Smoking Cessation; Tobacco Use Disorder | 2006 |
Effects of exposure of youths at risk for smoking to television advertising for nicotine replacement therapy and Zyban: an experimental study.
Topics: Adolescent; Adolescent Behavior; Advertising; Bupropion; Child; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation; Television | 2006 |
Transdermal nicotine for smoking cessation in postmenopausal women.
Topics: Administration, Cutaneous; Bupropion; Chest Pain; Counseling; Double-Blind Method; Drug Eruptions; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Logistic Models; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Postmenopause; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Treatment Outcome | 2007 |
The costs and effectiveness of different benefit designs for treating tobacco dependence: results from a randomized trial.
Topics: Adolescent; Adult; Behavior Therapy; Bupropion; Female; Humans; Insurance Coverage; Insurance, Health; Male; Middle Aged; Nicotine; Smoking Cessation; Socioeconomic Factors; Tobacco Use Disorder | 2006 |
Randomized trial of an intervention to facilitate recycling for relapsed smokers.
Topics: Adult; Aged; Behavior Therapy; Bupropion; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Patient Satisfaction; Retreatment; Secondary Prevention; Smoking Cessation; Tobacco Use Disorder; United States; Veterans | 2006 |
Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment.
Topics: 3' Untranslated Regions; Adult; Bupropion; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Genotype; Humans; Male; Middle Aged; Minisatellite Repeats; Nicotine; Nicotinic Agonists; Polymorphism, Genetic; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2007 |
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention.
Topics: Administration, Inhalation; Adult; Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Secondary Prevention; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2007 |
Subjective reactivity to the first cigarette of the day as a predictor of smoking relapse: a preliminary study.
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Circadian Rhythm; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Outcome Assessment, Health Care; Prognosis; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2007 |
A randomized trial of smoking cessation. Medication versus motivation.
Topics: Adult; Bupropion; Female; Humans; Male; Motivation; Nicotine; Prospective Studies; Smoking Cessation | 2007 |
A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Nicotine; Patient Compliance; Placebos; Polymethacrylic Acids; Polyvinyls; Secondary Prevention; Smoking Prevention; Tobacco Use Cessation Devices; Treatment Outcome | 2007 |
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Sample Size; Schizophrenia; Schizophrenic Psychology; Smoking Cessation | 2007 |
Efficacy of bupropion alone and in combination with nicotine gum.
Topics: Administration, Cutaneous; Adult; Bupropion; Chewing Gum; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2007 |
Bupropion and nicotine patch as smoking cessation aids in alcoholics.
Topics: Administration, Cutaneous; Adult; Alcoholism; Bupropion; Community Health Services; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Nebraska; Neurotransmitter Uptake Inhibitors; Nicotine; Nicotinic Agonists; Patient Compliance; Research Design; Smoking Cessation; Smoking Prevention; Substance Abuse Treatment Centers; Time Factors; Tobacco Use Disorder; Treatment Outcome; Veterans | 2007 |
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.
Topics: Administration, Cutaneous; Adult; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors | 2008 |
Smoking cessation medication use among pregnant and postpartum smokers.
Topics: Adult; Bupropion; Counseling; Educational Status; Female; Health Care Costs; Humans; Marital Status; Nicotine; Obstetrics; Parity; Patient Education as Topic; Postpartum Period; Practice Patterns, Physicians'; Pregnancy; Prenatal Care; Smoking; Smoking Cessation | 2008 |
Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome | 2008 |
Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity.
Topics: Adult; Antidepressive Agents, Second-Generation; Black or African American; Bupropion; Counseling; Female; Hispanic or Latino; Humans; Male; Middle Aged; Nicotine; Polypharmacy; Smoking Cessation; Tobacco Use Disorder; White People | 2008 |
Molecular genetics of successful smoking cessation: convergent genome-wide association study results.
Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Bupropion; Chromosome Mapping; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Genetic Markers; Genetic Predisposition to Disease; Genetic Variation; Genome; Humans; Male; Monte Carlo Method; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2008 |
Comparing the tolerability and effectiveness of two treatment regimens in a smoking clinic.
Topics: Administration, Cutaneous; Ambulatory Care Facilities; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Treatment Outcome; Veterans | 2008 |
Extended cognitive behavior therapy for cigarette smoking cessation.
Topics: Adult; Bupropion; Carbon Monoxide; Cognitive Behavioral Therapy; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
Topics: Administration, Cutaneous; Adult; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Dropouts; Psychiatric Status Rating Scales; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2008 |
Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation.
Topics: Bupropion; Community Pharmacy Services; Cotinine; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder | 2009 |
Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Cost-Benefit Analysis; Germany; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Physicians, Family; Primary Health Care; Reimbursement, Incentive; Smoking Cessation | 2009 |
Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking.
Topics: Adult; Black or African American; Bupropion; Combined Modality Therapy; Directive Counseling; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Prospective Studies; Smoking Cessation; Tobacco Use Disorder | 2009 |
Effect of varying levels of disease management on smoking cessation: a randomized trial.
Topics: Administration, Cutaneous; Adult; Bupropion; Combined Modality Therapy; Counseling; Disease Management; Female; Humans; Male; Middle Aged; Nicotine; Primary Health Care; Single-Blind Method; Smoking Cessation; Social Support; Tobacco Use Disorder; Young Adult | 2009 |
Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.
Topics: Administration, Cutaneous; Administration, Inhalation; Adolescent; Adult; Aged; Anxiety; Bupropion; Comorbidity; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Odds Ratio; Recurrence; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Young Adult | 2009 |
Extended treatment of older cigarette smokers.
Topics: Aged; Aged, 80 and over; Bupropion; Cognitive Behavioral Therapy; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Program Evaluation; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2009 |
Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Delayed-Action Preparations; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2009 |
Nicotine gum treatment before smoking cessation: a randomized trial.
Topics: Bupropion; Chewing Gum; Humans; Nicotine; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices; Weight Gain | 2009 |
A randomised trial of glucose tablets to aid smoking cessation.
Topics: Administration, Oral; Adult; Bupropion; Combined Modality Therapy; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; Glucose; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychotherapy, Group; Smoking Cessation; Tablets; Tobacco Use Disorder | 2010 |
A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies.
Topics: Administration, Cutaneous; Adult; Bupropion; Counseling; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Placebos; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Tablets; Treatment Outcome | 2009 |
Acute effects of pharmacotherapies in blood pressure in normotensive moderate smokers.
Topics: Adult; Blood Pressure; Bupropion; Cross-Over Studies; Female; Heart Rate; Humans; Male; Middle Aged; Nicotine; Single-Blind Method; Smoking; Smoking Cessation; Time Factors; Treatment Outcome | 2009 |
Do smokers know what we're talking about? The construct validity of nicotine dependence questionnaire measures.
Topics: Administration, Oral; Adult; Bupropion; Chewing Gum; Combined Modality Therapy; Counseling; Depression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motivation; Nicotine; Personality Inventory; Psychometrics; Reproducibility of Results; Smoking; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2009 |
A bupropion smoking cessation clinical trial for cancer patients.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Depression; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Nicotinic Agonists; Prevalence; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence.
Topics: Adult; Affect; Bupropion; Chewing Gum; Cognitive Behavioral Therapy; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Psychometrics; Secondary Prevention; Self Efficacy; Smoking Cessation; Social Support; Stress, Psychological; Tobacco Use Disorder; Treatment Outcome | 2010 |
Development of the Brief Wisconsin Inventory of Smoking Dependence Motives.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Data Collection; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Motivation; Nicotine; Surveys and Questionnaires; Tobacco Use Disorder | 2010 |
A pilot study combining individual-based smoking cessation counseling, pharmacotherapy, and dental hygiene intervention.
Topics: Adult; Attitude to Health; Bupropion; Counseling; Dental Care; Feasibility Studies; Female; Humans; Male; Nicotine; Patient Satisfaction; Periodontal Diseases; Periodontics; Pilot Projects; Smoking Cessation; Surveys and Questionnaires; Switzerland; Tobacco Use Disorder | 2010 |
If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bupropion; Cost-Benefit Analysis; Counseling; Data Interpretation, Statistical; Dopamine Uptake Inhibitors; Female; Health Care Costs; Humans; Male; Middle Aged; National Health Programs; Netherlands; Nicotine; Nicotinic Agonists; Quality-Adjusted Life Years; Reimbursement Mechanisms; Smoking; Smoking Cessation; Statistics as Topic; Time Factors; Treatment Outcome; Young Adult | 2010 |
Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.
Topics: Adolescent; Anxiety Disorders; Bupropion; Counseling; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Interview, Psychological; Logistic Models; Male; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2011 |
Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Black or African American; Bupropion; Cotinine; Counseling; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Female; Genotype; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Kansas; Male; Middle Aged; Motivation; Nicotine; Oxidoreductases, N-Demethylating; Patient Education as Topic; Patient Selection; Phenotype; Recurrence; Saliva; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2011 |
Smoker characteristics and smoking-cessation milestones.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Recurrence; Sex Factors; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Tobacco Use Disorder; Treatment Failure | 2011 |
Tobacco withdrawal components and their relations with cessation success.
Topics: Adult; Affect; Bupropion; Double-Blind Method; Humans; Multivariate Analysis; Nicotine; Nicotinic Agonists; Recurrence; Regression Analysis; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2011 |
Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.
Topics: Adult; Aged; Bupropion; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2011 |
Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program.
Topics: Behavior Therapy; Bupropion; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Placebos; Prognosis; Smoking; Smoking Cessation; Treatment Outcome | 2011 |
Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Breath Tests; Bupropion; Carbon Monoxide; Chewing Gum; Cluster Analysis; Counseling; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Primary Health Care; Program Evaluation; Psychological Theory; Smoking; Smoking Cessation; Social Class; Spain; Spouses; Time Factors; Transdermal Patch; Treatment Outcome; Young Adult | 2011 |
The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy.
Topics: Administration, Intranasal; Black People; Body Mass Index; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Linear Models; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Placebos; Recurrence; Self Report; Severity of Illness Index; Sex Factors; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Transdermal Patch; White People | 2011 |
Smoking cessation in primary care - a randomized controlled trial of bupropione, nicotine replacements, CBT and a minimal intervention.
Topics: Adult; Bupropion; Cognitive Behavioral Therapy; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Primary Health Care; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Treatment Outcome | 2011 |
Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Drug Therapy, Combination; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Substance-Related Disorders; Tobacco Use Disorder; Treatment Outcome | 2012 |
Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation.
Topics: Adult; Alleles; Bupropion; Female; Genetic Association Studies; Humans; Male; Middle Aged; Nicotine; Polymorphism, Single Nucleotide; Receptors, Galanin; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2012 |
Isolating the role of psychological dysfunction in smoking cessation: relations of personality and psychopathology to attaining cessation milestones.
Topics: Adult; Bupropion; Counseling; Defense Mechanisms; Female; Humans; Male; Mental Disorders; Nicotine; Personality; Psychiatric Status Rating Scales; Recurrence; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder; Treatment Outcome | 2012 |
Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances.
Topics: Adolescent; Benzazepines; Bupropion; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Male; Nicotine; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Quinoxalines; Reproducibility of Results; Risk Factors; Smoking Cessation; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2014 |
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Female; Genotype; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Quinoxalines; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Varenicline | 2013 |
Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
Topics: Adolescent; Adult; Affect; Aged; Benzazepines; Bupropion; Combined Modality Therapy; Counseling; Delayed-Action Preparations; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Treatment Outcome; Varenicline; Young Adult | 2013 |
Do atypical antipsychotics really enhance smoking reduction more than typical ones?: the effects of antipsychotics on smoking reduction in patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Bupropion; Dose-Response Relationship, Drug; Female; Humans; Linear Models; Male; Middle Aged; Nicotine; Schizophrenia; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices | 2013 |
Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
Topics: Adult; Base Sequence; Bupropion; Cytochrome P-450 CYP2A6; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Nerve Tissue Proteins; Nicotine; Proportional Hazards Models; Receptors, Nicotinic; Recurrence; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome | 2014 |
A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION).
Topics: Benzazepines; Bupropion; Canada; Female; Health Services Accessibility; Humans; Insurance, Health; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2014 |
Smoking cessation in smokers who smoke menthol and non-menthol cigarettes.
Topics: Administration, Cutaneous; Adult; Bupropion; Combined Modality Therapy; Counseling; Double-Blind Method; Drug Therapy, Combination; History, 15th Century; Humans; Longitudinal Studies; Male; Menthol; Nicotine; Sex Factors; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices; Treatment Failure; Treatment Outcome | 2014 |
Paths to tobacco abstinence: A repeated-measures latent class analysis.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2015 |
Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.
Topics: Adult; Aged; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Diagnosis, Dual (Psychiatry); House Calls; Humans; Male; Middle Aged; Nicotine; Schizophrenic Psychology; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2017 |
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bupropion; Cohort Studies; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Mood Disorders; Nicotine; Smoking Cessation; Varenicline; Young Adult | 2016 |
Anhedonia: Its Dynamic Relations With Craving, Negative Affect, and Treatment During a Quit Smoking Attempt.
Topics: Adult; Anhedonia; Bupropion; Craving; Female; Humans; Male; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2017 |
Mediators of the effect of nicotine pre-treatment on quitting smoking.
Topics: Adult; Behavior Therapy; Bupropion; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Premedication; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; Varenicline | 2018 |
Self-initiated gradual smoking reduction among community correction smokers.
Topics: Adult; Age of Onset; Black or African American; Bupropion; Cigar Smoking; Cigarette Smoking; Counseling; Criminal Law; Female; Humans; Male; Nicotine; Nicotinic Agonists; Smoking Cessation; Smoking Cessation Agents; Smoking Reduction; Substance Withdrawal Syndrome; White People | 2019 |
Smoking abstinence symptoms across 67 days compared with randomized controls-Moderation by nicotine replacement therapy, bupropion, and negative-affect traits.
Topics: Administration, Cutaneous; Adult; Anxiety; Behavior Therapy; Bupropion; Cigarette Smoking; Craving; Female; Humans; Male; Nicotine; Smoking Cessation; Smoking Cessation Agents; Substance Withdrawal Syndrome | 2019 |
Multiple Pharmacotherapy Adaptations for Smoking Cessation Based on Treatment Response in Black Adults Who Smoke: A Randomized Clinical Trial.
Topics: Adult; Bupropion; Ethnicity; Female; Humans; Male; Middle Aged; Minority Groups; Nicotine; Smoking; Smoking Cessation; Varenicline | 2023 |
Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial.
Topics: Bupropion; COVID-19; Female; Humans; Male; Middle Aged; Nicotine; Pandemics; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
251 other study(ies) available for nicotine and bupropion
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Two products join ranks of smoking cessation treatments.
Topics: Administration, Inhalation; Bupropion; Cholinergic Agents; Humans; Neurotransmitter Uptake Inhibitors; Nicotine; Smoking Cessation | 1997 |
Treating tobacco addiction--nicotine or no nicotine?
Topics: Antidepressive Agents; Bupropion; Humans; Nicotine; Nortriptyline; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1997 |
Zyban: a new aid to smoking cessation treatment--will it work for psychiatric patients?
Topics: Antidepressive Agents, Second-Generation; Bupropion; Drug Interactions; Drug Therapy, Combination; Humans; Mental Disorders; Nicotine; Psychotropic Drugs; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 1999 |
Ask the doctor. I am trying to help my husband stop smoking. He tried to use the antidepressant Zyban, but it didn't work. He has also tried the nicotine patch, and that didn't work either. Is there any reason why he shouldn't try both together?
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Humans; Male; Nicotine; Smoking Cessation | 1999 |
Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs.
Topics: Animals; Body Temperature; Bupropion; Cocaine; Discrimination, Psychological; Female; Male; Membrane Potentials; Mice; Mice, Inbred ICR; Molecular Structure; Motor Activity; Nicotine; Oocytes; Pain; Piperazines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Recombinant Proteins; Seizures; Structure-Activity Relationship; Tropanes; Xenopus laevis | 1999 |
Bupropion or patch for smoking cessation?
Topics: Administration, Cutaneous; Adolescent; Adult; Bupropion; Combined Modality Therapy; Double-Blind Method; Humans; Nicotine; Randomized Controlled Trials as Topic; Reproducibility of Results; Smoking Cessation; Treatment Outcome | 1999 |
New strategies for smoking cessation.
Topics: Algorithms; Antidepressive Agents, Second-Generation; Bupropion; Counseling; Decision Trees; Humans; Nicotine; Practice Guidelines as Topic; Smoking Cessation; Smoking Prevention; United States; United States Agency for Healthcare Research and Quality | 1999 |
Smoking cessation.
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Humans; Nicotine; Odds Ratio; Smoking Cessation | 1999 |
Pharmacological aids to smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Nicotine; Smoking Cessation | 1999 |
Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation.
Topics: Administration, Cutaneous; Adult; Bupropion; Cost-Benefit Analysis; Decision Trees; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Nicotinic Agonists; Occupational Health; Smoking Cessation; United States | 2000 |
Pharmacotherapy for smoking cessation.
Topics: Bupropion; Contraindications; Humans; Nicotine; Smoking; Smoking Cessation | 2000 |
Which of the new smoking cessation treatments is best?
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Nicotine; Smoking Cessation | 2000 |
Are there any new strategies to increase the success rate for smoking cessation?
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Bupropion; Humans; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 1998 |
A 36-year-old woman who smokes cigarettes.
Topics: Adult; Age of Onset; Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Child; Cognitive Behavioral Therapy; Cost of Illness; Female; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2000 |
Bupropion is a nicotinic antagonist.
Topics: Animals; Bupropion; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred ICR; Motor Activity; Nicotine; Nicotinic Antagonists; Receptors, Nicotinic | 2000 |
Smoking cessation: which aids are worthwhile?
Topics: Antidepressive Agents, Second-Generation; Bupropion; Counseling; Family Practice; Humans; Netherlands; Nicotine; Nicotinic Agonists; Patient Education as Topic; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Treatment Outcome | 2000 |
Smoking cessation guidelines for health professionals: an update. Health Education Authority.
Topics: Behavior Therapy; Bupropion; Evidence-Based Medicine; Family Practice; Female; Humans; National Health Programs; Nicotine; Patient Education as Topic; Pregnancy; Smoking Cessation; State Medicine; United Kingdom | 2000 |
Pharmacologic aids to smoking cessation.
Topics: Bupropion; Humans; Nicotine; Smoking Cessation | 2000 |
[A drug for smoking cessation?].
Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Bupropion; Cholinergic Agents; Humans; Nicotine; Smoking; Smoking Cessation | 2001 |
Newly available treatments for nicotine addiction. Smokers wanting help with stopping now have effective treatment options.
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder | 2001 |
Smoking cessation. The key to treating older smokers? Don't quit helping.
Topics: Aged; Antidepressive Agents, Second-Generation; Bupropion; Drug Administration Schedule; Female; Humans; Male; Nicotine; Smoking Cessation; Treatment Outcome | 2001 |
Aids to quitting tobacco use: how important are they outside controlled trials?
Topics: Bupropion; Female; Humans; Male; Middle Aged; Minnesota; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2001 |
[Known methods can reduce tobacco dependence drastically].
Topics: Antidepressive Agents, Second-Generation; Bupropion; Global Health; Humans; Nicotine; Psychotherapy; Smoking; Smoking Cessation; Smoking Prevention | 2001 |
General Practitioners' views on the provision of nicotine replacement therapy and bupropion.
Topics: Antidepressive Agents, Second-Generation; Attitude of Health Personnel; Bupropion; Data Collection; Drug Prescriptions; Female; Humans; Insurance Benefits; Insurance, Pharmaceutical Services; Male; Nicotine; Physicians, Family; Practice Patterns, Physicians'; Smoking Cessation; State Medicine; Surveys and Questionnaires; United Kingdom | 2001 |
Amfebutamone/bupropion for smoking cessation: new preparation. Nicotine replacement therapy is safer.
Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Bupropion; Clinical Trials as Topic; France; Ganglionic Stimulants; Nicotine; Smoking Cessation; Treatment Outcome | 2001 |
Treatment of nicotine addiction.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Behavior Therapy; Bupropion; Central Nervous System Stimulants; Chewing Gum; Cost-Benefit Analysis; Counseling; Dentist-Patient Relations; Dopamine Uptake Inhibitors; Humans; Medical History Taking; Nebulizers and Vaporizers; Nicotine; Patient Education as Topic; Polymethacrylic Acids; Polyvinyls; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2000 |
[Zyban in smoking cessation--where is physician's ethic?].
Topics: Antidepressive Agents, Second-Generation; Bupropion; Ethics, Medical; Humans; Nicotine; Smoking Cessation | 2001 |
Nicotine-like discriminative stimulus effects of bupropion in rats.
Topics: Animals; Bupropion; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Long-Evans | 2002 |
Nicotine and bupropion share a similar discriminative stimulus effect.
Topics: Animals; Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Stimulus; Injections, Subcutaneous; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Smoking Cessation | 2002 |
The power of the press in smokers' attempts to quit.
Topics: Bupropion; Humans; Mass Media; Nicotine; Smoking Cessation; Smoking Prevention | 2002 |
Smoking cessation. Put your addiction in the ashtray for good.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Nicotine; Nicotinic Agonists; Smoking Cessation | 2002 |
[Bupropion. An antidepressant used to help smoking cessation].
Topics: Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Patient Education as Topic; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder; Treatment Outcome | 2002 |
Treatment of tobacco use and dependence.
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Myocardial Ischemia; Nicotine; Smoking Cessation | 2002 |
Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
Topics: Animals; Bupropion; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electric Stimulation; Hippocampus; In Vitro Techniques; Kinetics; Male; Mecamylamine; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Symporters | 2002 |
Improving cessation rates?
Topics: Administration, Cutaneous; Adolescent; Adult; Bupropion; Combined Modality Therapy; Double-Blind Method; Follow-Up Studies; Humans; Nicotine; Patient Compliance; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Smoking Cessation; Treatment Outcome | 1999 |
Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
Topics: Administration, Cutaneous; Adult; Benchmarking; Bupropion; Chewing Gum; Cost-Benefit Analysis; Counseling; Dopamine Uptake Inhibitors; Evidence-Based Medicine; Health Benefit Plans, Employee; Humans; Insurance Carriers; Labor Unions; Male; Nicotine; Occupations; Outcome Assessment, Health Care; Patient Satisfaction; Pilot Projects; Program Evaluation; Smoking Cessation; Washington | 2002 |
Investigating the actions of bupropion on dependence-related effects of nicotine in rats.
Topics: Animals; Avoidance Learning; Bupropion; Conditioning, Operant; Discrimination Learning; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Antagonism; Male; Nicotine; Random Allocation; Rats; Reference Values; Tobacco Use Disorder | 2003 |
[Smoking, nicotine dependence and detoxification therapies].
Topics: Administration, Cutaneous; Administration, Intranasal; Adrenergic alpha-Agonists; Antidepressive Agents; Bupropion; Chewing Gum; Clonidine; Dopamine Uptake Inhibitors; Health Promotion; Humans; Nicotine; Smoking; Smoking Cessation; Tobacco Use Disorder | 2002 |
Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Bupropion; Drug Administration Schedule; Electric Stimulation; Male; Nicotine; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2003 |
Cost-effectiveness analysis of the first-line therapies for nicotine dependence.
Topics: Adult; Age Factors; Aged; Bupropion; Cohort Studies; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Middle Aged; Models, Economic; Nicotine; Sex Factors; Smoking Cessation; Tobacco Use Disorder | 2003 |
Effect of bupropion on nicotine self-administration in rats.
Topics: Animals; Antidepressive Agents; Apomorphine; Bupropion; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Methamphetamine; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Sucrose | 2003 |
Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats.
Topics: Animals; Bupropion; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Eating; Feeding Behavior; Male; Nicotine; Rats; Rats, Wistar; Reinforcement, Psychology; Reward; Self Administration; Tobacco Use Disorder | 2003 |
Behavioral and biochemical investigations of bupropion metabolites.
Topics: Amphetamine; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Binding, Competitive; Bupropion; Cell Line; Discrimination Learning; Humans; Male; Nicotine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Rubidium Radioisotopes; Transfection | 2003 |
Bupropion-induced somnambulism.
Topics: Adult; Amnesia; Bupropion; Dopamine Uptake Inhibitors; Humans; Male; Nicotine; Smoking Cessation; Somnambulism; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2003 |
The place of pharmacotherapy products in smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Cost-Benefit Analysis; Drug Costs; Ganglionic Stimulants; Humans; Nicotine; Patient Selection; Smoking Cessation; Tobacco Use Disorder | 2003 |
Stopping smoking can cause constipation.
Topics: Bupropion; Constipation; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Psychiatric Status Rating Scales; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2003 |
The cost effectiveness of pharmacotherapies for smoking cessation: necessary but not sufficient?
Topics: Administration, Cutaneous; Australia; Bupropion; Cost-Benefit Analysis; Decision Making; Drug Costs; Health Services Needs and Demand; Humans; Nicotine; Patient Acceptance of Health Care; Smoking; Smoking Cessation; Treatment Outcome | 2003 |
PREP Self-Assessment example.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Female; Humans; Nicotine; Smoking Cessation | 2004 |
Latinos report less use of pharmaceutical aids when trying to quit smoking.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Colorado; Counseling; Female; Health Care Surveys; Hispanic or Latino; Humans; Logistic Models; Male; Middle Aged; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Physician's Role; Smoking Cessation; Tobacco Use Disorder; White People | 2004 |
Self-care secrets. Giving up smoking for good. Use these strategies to help you stop smoking.
Topics: Bupropion; Diabetes Complications; Humans; Nicotine; Self Care; Smoking; Smoking Cessation; Smoking Prevention; United States | 2003 |
Initial uptake and evidence of safe prescribing practice with Buproprion (Zyban).
Topics: Adolescent; Adult; Age Factors; Aged; Bupropion; Databases, Factual; Dopamine Uptake Inhibitors; Drug Interactions; Drug Prescriptions; Drug Utilization Review; Family Practice; Female; Humans; Ireland; Logistic Models; Male; Middle Aged; National Health Programs; Nicotine; Safety; Smoking Cessation; Tobacco Use Disorder | 2004 |
[Recommendation of good practice: Therapeutic strategies, with or without the assistance of medicine-based treatment, for stopping smoking (May 2003)].
Topics: Adolescent; Alcohol Drinking; Bupropion; Cotinine; Female; Humans; MEDLINE; Nicotine; Pregnancy; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
Bupropion (Zyban, Wellbutrin) inhibits nicotine-induced viral reactivation in herpes simplex virus type 1 latent rabbits.
Topics: Animals; Bupropion; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Interactions; Eye; Female; Herpesvirus 1, Human; Male; Nicotine; Rabbits; Virus Latency; Virus Shedding | 2004 |
Assessing harmful effects in systematic reviews.
Topics: Anticonvulsants; Antipsychotic Agents; Bupropion; Delayed-Action Preparations; Humans; Meta-Analysis as Topic; Nicotine; Observation; Quality Control; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Schizophrenia; Smoking Cessation; Treatment Outcome | 2004 |
Tobacco cessation pharmacotherapy use among First Nations persons residing within British Columbia.
Topics: Adult; Age Factors; British Columbia; Bupropion; Databases, Factual; Dopamine Uptake Inhibitors; Female; Ganglionic Stimulants; Humans; Indians, North American; Male; Nicotine; Sex Factors; Smoking Cessation; Tobacco Use Disorder | 2004 |
GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
Topics: Bupropion; England; Health Care Surveys; Humans; Nicotine; Practice Patterns, Physicians'; Smoking Cessation; Wales | 2004 |
Nicotinic receptor subtypes in rat hippocampal slices are differentially sensitive to desensitization and early in vivo functional up-regulation by nicotine and to block by bupropion.
Topics: Animals; Bupropion; Dose-Response Relationship, Drug; Hippocampus; In Vitro Techniques; Nicotine; Nicotinic Antagonists; Protein Subunits; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Up-Regulation | 2005 |
[Drugs for smoking cessation].
Topics: Bupropion; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotine; Smoking; Smoking Cessation; Smoking Prevention | 2005 |
National trends in the provision of smoking cessation aids within the Veterans Health Administration.
Topics: Adult; Aged; Bupropion; Chewing Gum; Databases as Topic; Drug Utilization Review; Hospitals, Veterans; Humans; Middle Aged; Nicotine; Pharmacy Service, Hospital; Smoking; Smoking Cessation; Smoking Prevention; United States; United States Department of Veterans Affairs; Veterans | 2005 |
[ABC of smoking cessation. Bupropion and other drugs in non-nicotine therapy].
Topics: Administration, Cutaneous; Antidepressive Agents; Bupropion; Humans; Nicotine; Smoking Cessation | 2004 |
General practitioners' views on and referral to NHS smoking cessation services.
Topics: Adult; Antidepressive Agents, Second-Generation; Attitude of Health Personnel; Bupropion; Female; Financing, Government; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Physicians, Family; Referral and Consultation; Smoking Cessation; State Medicine; United Kingdom | 2005 |
Nicotine replacement.
Topics: Antidepressive Agents, Second-Generation; Bupropion; Ganglionic Stimulants; Half-Life; Humans; Metabolic Clearance Rate; Nicotine; Smoking Cessation | 2005 |
[Veracity of smokers' reports of abstinence at smoking cessation clinics].
Topics: Adult; Breath Tests; Bupropion; Carbon Monoxide; Data Interpretation, Statistical; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; Nicotine; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Smoking Cessation; Spain; Time Factors | 2005 |
Outcomes from an outpatient smoking-cessation clinic.
Topics: Ambulatory Care Facilities; Antidepressive Agents, Second-Generation; Bupropion; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking Cessation; Treatment Outcome | 2005 |
Recent quitters' interest in recycling and harm reduction.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Bupropion; Cross-Sectional Studies; Databases as Topic; Dopamine Uptake Inhibitors; Female; Ganglionic Stimulants; Harm Reduction; Humans; Male; Middle Aged; Nicotine; Recurrence; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires; Tobacco Use Disorder | 2004 |
The impact of socioeconomic and demographic factors on the utilization of smoking cessation medications in patients hospitalized with cardiovascular disease in Nova Scotia, Canada.
Topics: Administration, Cutaneous; Bupropion; Cardiovascular Diseases; Chewing Gum; Data Collection; Demography; Female; Hospitalization; Humans; Inpatients; Male; Middle Aged; Nicotine; Nova Scotia; Smoking; Smoking Cessation; Socioeconomic Factors; Time Factors | 2005 |
Awareness and use of smoking cessation treatments among diabetic patients.
Topics: Aged; Antidepressive Agents, Second-Generation; Bupropion; Diabetes Mellitus, Type 2; Female; Health Behavior; Health Knowledge, Attitudes, Practice; Humans; Male; Middle Aged; Nicotine; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2005 |
What's new in Nicotine and Tobacco Research?
Topics: Advertising; Bupropion; Deception; Dopamine Uptake Inhibitors; Emotions; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry | 2004 |
Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.
Topics: Animals; Antipsychotic Agents; Biogenic Monoamines; Bupropion; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Evoked Potentials, Auditory; Haloperidol; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Schizophrenia | 2005 |
An innovative tobacco use cessation program for military dental clinics.
Topics: Bupropion; Central Nervous System Stimulants; Counseling; Dopamine Uptake Inhibitors; Humans; Military Dentistry; Military Personnel; Nicotine; Physical Fitness; Program Evaluation; Smoking; Tobacco Use Cessation; Tobacco Use Disorder | 2005 |
Impact of UK policy initiatives on use of medicines to aid smoking cessation.
Topics: Bupropion; Drug Utilization; Health Policy; Humans; Nicotine; Smoking Cessation; United Kingdom | 2005 |
PHARMAC and tobacco control in New Zealand: two licensed funded options are already available.
Topics: Administration, Cutaneous; Bupropion; Cost-Benefit Analysis; Drug Industry; Evidence-Based Medicine; Humans; Licensure; New Zealand; Nicotine; Nortriptyline; Practice Guidelines as Topic; Smoking Cessation; Tobacco Use Disorder; United States | 2005 |
[Medication for ending tobacco dependency. Current state].
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Humans; Nicotine; Piperidines; Pyrazoles; Quinoxalines; Receptors, Nicotinic; Rimonabant; Smoking Cessation; Time Factors; Tobacco Use Disorder; Varenicline | 2005 |
What to do with a patient who smokes.
Topics: Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Clonidine; Counseling; Hotlines; Humans; Nicotine; Nortriptyline; Physician's Role; Smoking; Smoking Cessation; Tobacco Use Disorder; United States | 2005 |
Smoking cessation treatment in primary care: prospective cohort study.
Topics: Adolescent; Adult; Aged; Bupropion; Contraindications; Drug Prescriptions; England; Female; Health Services Research; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Selection; Poverty; Practice Patterns, Physicians'; Primary Health Care; Prospective Studies; Smoking Cessation; Smoking Prevention | 2005 |
Characterization of nicotine's ability to serve as a negative feature in a Pavlovian appetitive conditioning task in rats.
Topics: Amphetamine; Animals; Arecoline; Association Learning; Bupropion; Caffeine; Chlordiazepoxide; Conditioning, Classical; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Drug Interactions; Hexamethonium; Male; Mecamylamine; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Sucrose | 2006 |
Smoking status of Australian general practice patients and their attempts to quit.
Topics: Adolescent; Adult; Aged; Australia; Bupropion; Cross-Sectional Studies; Family Practice; Female; Humans; Male; Middle Aged; Nicotine; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2006 |
Bupropion attenuates nicotine abstinence syndrome in the rat.
Topics: Animals; Association Learning; Avoidance Learning; Bupropion; Conditioning, Classical; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Mecamylamine; Nicotine; Nicotinic Antagonists; Premedication; Rats; Rats, Sprague-Dawley; Social Environment; Substance Withdrawal Syndrome | 2006 |
What's new in nicotine & tobacco research?
Topics: Advertising; Bupropion; Deception; Dopamine Uptake Inhibitors; Humans; Nicotine; Research Design; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Industry; Tobacco Use Disorder; United States | 2005 |
Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Bupropion; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Self Administration; Smoking; Smoking Cessation; Sucrose | 2005 |
Tobacco cessation for the dental team: a practical guide part II: evidence-based interventions.
Topics: Bupropion; Central Nervous System Stimulants; Dental Care; Evidence-Based Medicine; Health Plan Implementation; Hotlines; Humans; Motivation; Nicotine; Pamphlets; Polymethacrylic Acids; Polyvinyls; Tobacco Use Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2005 |
Pharmacotherapy and smoking cessation at a tobacco dependence clinic.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Behavior Therapy; Bupropion; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; New Jersey; Nicotine; Retrospective Studies; Smoking Cessation; Time Factors; Tobacco Use Disorder | 2006 |
A comparison of pharmacological tobacco cessation relapse rates.
Topics: Administration, Cutaneous; Adult; Ambulatory Care; Bupropion; Chewing Gum; Combined Modality Therapy; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Louisiana; Male; Middle Aged; Military Personnel; Naval Medicine; Nicotine; Nicotinic Agonists; Patient Education as Topic; Recurrence; Retrospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2006 |
Preexposure to nicotine alters the subsequent locomotor stimulant effects of bupropion in rats.
Topics: Animals; Behavior, Animal; Bupropion; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Uptake Inhibitors; Locomotion; Male; Nicotine; Random Allocation; Rats; Rats, Sprague-Dawley | 2006 |
Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practice.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Australia; Bupropion; Dopamine Uptake Inhibitors; Female; Health Care Surveys; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Substance-Related Disorders; Taurine; Tobacco Use Disorder | 2006 |
Smoking cessation advice for patients with chronic periodontitis.
Topics: Adult; Breath Tests; Bupropion; Carbon Monoxide; Central Nervous System Stimulants; Chronic Disease; Cohort Studies; Cotinine; Counseling; Dental Hygienists; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Nicotine; Patient Education as Topic; Periodontitis; Professional-Patient Relations; Saliva; Smoking; Smoking Cessation; Treatment Outcome | 2006 |
The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
Topics: Adult; Aged; Bupropion; Chewing Gum; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Nicotine; Quality-Adjusted Life Years; Smoking Cessation; Stroke; Sweden | 2006 |
Effect of bupropion on physiological measures of stress in smokers during nicotine withdrawal.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Pressure; Bupropion; Counseling; Epinephrine; Female; Heart Rate; Humans; Hydrocortisone; Male; Middle Aged; Nicotine; Norepinephrine; Smoking Cessation; Stress, Psychological; Substance Withdrawal Syndrome; Time Factors | 2006 |
[Success of smoking cessation in patients with chronic obstructive pulmonary disease].
Topics: Bupropion; Case-Control Studies; Female; Humans; Male; Middle Aged; Nicotine; Outcome Assessment, Health Care; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Turkey | 2006 |
Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison.
Topics: Adult; Age Factors; Americas; Bupropion; Cost-Benefit Analysis; Drug Costs; Europe; Female; Health Care Costs; Humans; Male; Markov Chains; Middle Aged; Nicotine; Primary Health Care; Recurrence; Sex Factors; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2006 |
[Smoking cessation after 12 months follow-up at a smoking cessation unit].
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Male; Nicotine; Nicotinic Agonists; Psychotherapy, Group; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2006 |
How to help smokers quit: Part 2.
Topics: Administration, Inhalation; Administration, Topical; Bupropion; Chewing Gum; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Polymethacrylic Acids; Polyvinyls; Smoking; Smoking Cessation; Tobacco Use Cessation Devices | 2006 |
An exploration of Latino smokers and the use of pharmaceutical aids.
Topics: Bupropion; Dopamine Uptake Inhibitors; Female; Focus Groups; Hispanic or Latino; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Acceptance of Health Care; Smoking; Smoking Cessation | 2006 |
Hemodynamic effects of a combination of bupropion and nicotine in anesthetized dogs.
Topics: Anesthesia; Animals; Antidepressive Agents, Second-Generation; Blood Pressure; Bupropion; Dogs; Drug Therapy, Combination; Female; Hemodynamics; Hypertension, Pulmonary; Male; Nicotine; Smoking Cessation | 2006 |
Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians.
Topics: Attitude of Health Personnel; Behavior Therapy; Bupropion; Cardiology; Family Practice; Female; Health Promotion; Health Surveys; Humans; Male; Middle Aged; Netherlands; Nicotine; Nicotinic Agonists; Physician's Role; Prevalence; Pulmonary Medicine; Sex Distribution; Smoking; Smoking Cessation; Smoking Prevention | 2007 |
Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Bupropion; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Presynaptic Terminals; Rats; Rats, Inbred F344; Receptors, Nicotinic; Reinforcement, Psychology; Rubidium Radioisotopes; Tobacco Use Disorder | 2006 |
Population effectiveness of pharmaceutical aids for smoking cessation: what is associated with increased success?
Topics: Bupropion; California; Cross-Sectional Studies; Environment; Humans; Nicotine; Pharmaceutic Aids; Program Evaluation; Proportional Hazards Models; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2006 |
A shot at quitting.
Topics: Binding Sites, Antibody; Blood-Brain Barrier; Bupropion; Clinical Trials as Topic; Combined Modality Therapy; Counseling; Drug Administration Schedule; Humans; Nicotine; Smoking Cessation; Tobacco Use Disorder; Vaccines | 2006 |
[Smoking cessation counseling center in a French hospital: Effectiveness at one year and predictors of outcome].
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Cognitive Behavioral Therapy; Female; France; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Outcome Assessment, Health Care; Outpatient Clinics, Hospital; Prospective Studies; Recurrence; Selective Serotonin Reuptake Inhibitors; Sex Factors; Smoking Cessation | 2006 |
General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies.
Topics: Adult; Attitude of Health Personnel; Attitude to Health; Bupropion; Family Practice; Female; Health Care Surveys; Humans; Intention; Internet; London; Male; Middle Aged; Nicotine; Physicians, Family; Qualitative Research; Safety; Smoking Cessation; Surveys and Questionnaires; Treatment Outcome | 2006 |
Can pharmacogenetics help smokers quit?
Topics: Antidepressive Agents, Second-Generation; Bupropion; Humans; Inactivation, Metabolic; Nicotine; Pharmacogenetics; Smoking; Smoking Cessation | 2006 |
[Weight gain and anxiety levels in recent ex-smokers].
Topics: Adult; Anxiety; Basal Metabolism; Breath Tests; Bupropion; Carbon Monoxide; Chewing Gum; Feeding Behavior; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Prospective Studies; Psychological Tests; Smoking Cessation; Weight Gain | 2007 |
Smoking characteristics and cessation in patients with thromboangiitis obliterans.
Topics: Adult; Amputation, Surgical; Bupropion; Chewing Gum; Combined Modality Therapy; Disease Progression; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Male; Nicotine; Nicotinic Agonists; Prevalence; Retrospective Studies; Smoking; Smoking Cessation; Spain; Thromboangiitis Obliterans; Time Factors; Treatment Outcome | 2006 |
[The path from cigarettes--with support it works better].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
Topics: Animals; Bupropion; Calcium; Cell Line; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; In Vitro Techniques; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptosomes | 2007 |
Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
Topics: Adult; Attitude of Health Personnel; Bupropion; Dopamine Uptake Inhibitors; Female; Health Education; Humans; Male; Middle Aged; New South Wales; Nicotine; Nicotinic Agonists; Pharmacies; Pharmacists; Smoking; Smoking Cessation; Smoking Prevention; Social Support; Surveys and Questionnaires | 2007 |
General practitioners' beliefs about effectiveness and intentions to recommend smoking cessation services: qualitative and quantitative studies.
Topics: Adult; Aged; Attitude of Health Personnel; Bupropion; Family Practice; Female; Health Care Surveys; Health Promotion; Health Services Accessibility; Humans; Intention; London; Male; Middle Aged; Nicotine; Physicians, Family; Practice Patterns, Physicians'; Qualitative Research; Smoking Cessation; Surveys and Questionnaires | 2007 |
Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
Topics: Australia; Bupropion; Cost-Benefit Analysis; Decision Support Techniques; Drug Costs; Humans; Life Expectancy; Nicotine; Reimbursement Mechanisms; Smoking; Smoking Cessation | 2007 |
Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.
Topics: Animals; Bupropion; Dopamine; Dose-Response Relationship, Drug; Male; Motor Activity; Nicotine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2007 |
Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
Topics: Animals; Antidepressive Agents; Bupropion; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mecamylamine; Nicotine; Nortriptyline; Rats; Smoking Cessation; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2007 |
Physician beliefs regarding effectiveness of tobacco dependence treatments: results from the NJ Health Care Provider Tobacco Survey.
Topics: Adult; Attitude of Health Personnel; Behavior Therapy; Bupropion; Female; Humans; Male; Middle Aged; New Jersey; Nicotine; Nicotinic Agonists; Patient Compliance; Practice Patterns, Physicians'; Risk Assessment; Sensitivity and Specificity; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2007 |
Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning.
Topics: Animals; Bupropion; Conditioning, Psychological; Dopamine; Dose-Response Relationship, Drug; Fear; Male; Mental Recall; Mice; Mice, Inbred C57BL; Nicotine; Norepinephrine; Smoking Cessation; Substance Withdrawal Syndrome | 2007 |
Nicotine vaccines for smoking cessation.
Topics: Bupropion; Canada; Clinical Trials as Topic; Humans; Nicotine; Nicotinic Agonists; Receptors, Nicotinic; Smoking; Smoking Cessation; Vaccination; Vaccines | 2007 |
An epidemic that deserves more attention: epidemiology, prevention, and treatment of smokeless tobacco.
Topics: Adolescent; Adult; Age Factors; Behavior Therapy; Bupropion; Child; Disease Outbreaks; Dopamine Uptake Inhibitors; Female; Humans; Male; Mouth Diseases; Nicotine; Nicotinic Agonists; Sex Factors; Tobacco Use Disorder; Tobacco, Smokeless; United States | 2007 |
Nicotine as a conditioned stimulus: impact of attention-deficit/hyperactivity disorder medications.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Bupropion; Cocaine; Conditioning, Operant; Conditioning, Psychological; Discrimination Learning; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Generalization, Psychological; Male; Methylphenidate; Nicotine; Nicotinic Antagonists; Piperazines; Propylamines; Rats; Rats, Sprague-Dawley | 2007 |
Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose.
Topics: Animals; Behavior, Animal; Bupropion; Conditioning, Operant; Cues; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Extinction, Psychological; Infusions, Intravenous; Injections, Intraperitoneal; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Self Administration | 2008 |
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Theoretical; Netherlands; Nicotine; Nortriptyline; Quality of Life; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2008 |
A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.
Topics: Alleles; Bupropion; Combined Modality Therapy; Cost of Illness; Cost-Benefit Analysis; Counseling; Dopamine Uptake Inhibitors; Genetic Testing; Humans; Models, Economic; Nicotine; Polymorphism, Genetic; Receptors, Dopamine D2; Smoking; Smoking Cessation | 2008 |
Heterogeneity in preferences for smoking cessation.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Ganglionic Stimulants; Humans; Likelihood Functions; Male; Models, Biological; Nicotine; Patient Satisfaction; Smoking Cessation; Tobacco Use Disorder | 2008 |
The truth about smoking cessation.
Topics: Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Humans; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline | 2007 |
Smoking cessation pharmacotherapy preferences in rural primary care.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Choice Behavior; Female; Health Knowledge, Attitudes, Practice; Humans; Kansas; Male; Middle Aged; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Primary Health Care; Rural Health Services; Rural Population; Secondary Prevention; Smoking; Smoking Cessation; Surveys and Questionnaires; Tobacco Use Disorder | 2008 |
Smoking cessation in clinical practice: predictors of six-month continuous abstinence in a sample of Greek smokers.
Topics: Adult; Bupropion; Case-Control Studies; Female; Follow-Up Studies; Greece; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome | 2008 |
Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
Topics: Administration, Cutaneous; Administration, Topical; Australia; Bupropion; Dopamine Uptake Inhibitors; Drug Therapy; Female; Health Expenditures; Humans; Incidence; Insurance, Health, Reimbursement; Male; Middle Aged; Nicotine; Nicotinic Agonists; Prevalence; Smoking; Smoking Cessation; Smoking Prevention | 2008 |
Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice.
Topics: Aggression; Animals; Anxiety; Behavior, Animal; Bupropion; Dopamine Uptake Inhibitors; Drug Administration Schedule; Exploratory Behavior; Ganglionic Stimulants; Male; Mice; Nicotine; Social Behavior; Tobacco Use Disorder | 2008 |
Stat bite: Medicaid coverage of tobacco-dependence treatments.
Topics: Administration, Cutaneous; Administration, Intranasal; Administration, Oral; Antidepressive Agents, Second-Generation; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Insurance Coverage; Male; Medicaid; Nicotine; Nicotinic Agonists; Pregnancy; Pregnancy Complications; Quinoxalines; Tobacco Use Disorder; United States; Varenicline | 2008 |
Helping patients kick the "other" habit.
Topics: Adult; Bupropion; Evidence-Based Medicine; Humans; Leukoplakia, Oral; Male; Nicotine; Tobacco Use Cessation | 2008 |
[Factors associated with abstinence in a smoking cessation program].
Topics: Bupropion; Epidemiologic Methods; Female; Humans; Interview, Psychological; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation | 2008 |
Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Costs and Cost Analysis; Drug Costs; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Quinoxalines; Smoking; Smoking Cessation; United States; Varenicline | 2008 |
Bupropion differentially alters the aversive, locomotor and rewarding properties of nicotine in CD-1 mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Bupropion; Conditioning, Operant; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Male; Mice; Motor Activity; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Taste | 2008 |
High rate of smoking abstinence in COPD patients: Smoking cessation by hospitalization.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Female; Follow-Up Studies; Ganglionic Stimulants; Hospitalization; Humans; Male; Middle Aged; Nicotine; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome | 2008 |
Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Bupropion; Conditioning, Psychological; Drug Administration Schedule; Electric Stimulation; Male; Nicotine; Rats; Rats, Wistar; Receptors, Nicotinic; Reward; Substance Withdrawal Syndrome | 2008 |
Rate-dependent effects of bupropion on nicotine self-administration and food-maintained responding in rats.
Topics: Animals; Bupropion; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Food; Food Deprivation; Male; Motivation; Nicotine; Nicotinic Agonists; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Satiety Response; Self Administration | 2008 |
[Summary of the practice guideline 'Smoking cessation' from the Dutch College of General Practitioners].
Topics: Bupropion; Chronic Disease; Family Practice; Female; Humans; Male; Motivation; Netherlands; Nicotine; Nortriptyline; Practice Patterns, Physicians'; Smoking Cessation; Social Support; Societies, Medical | 2008 |
Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies.
Topics: Adult; Attitude to Health; Behavior, Addictive; Bupropion; Cross-Sectional Studies; England; Female; Health Knowledge, Attitudes, Practice; Humans; Intention; Male; Middle Aged; Nicotine; Patient Compliance; Qualitative Research; Smoking; Smoking Cessation; Smoking Prevention; Surveys and Questionnaires | 2008 |
Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion.
Topics: Animals; Bupropion; Depression; Dose-Response Relationship, Drug; Drug Administration Routes; Gene Expression; Male; Nicotine; Raphe Nuclei; Rats; Rats, Wistar; RNA, Messenger; Serotonin Plasma Membrane Transport Proteins; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement.
Topics: Animals; Bupropion; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Schedule; Infusions, Intravenous; Male; Nicotine; Nicotinic Agonists; Norepinephrine; Rats; Rats, Long-Evans; Receptors, Nicotinic; Reinforcement Schedule; Self Administration; Smoking Cessation | 2009 |
An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.
Topics: Algorithms; Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Consensus; Decision Support Techniques; Delphi Technique; Humans; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking Cessation; Varenicline | 2009 |
Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT.
Topics: Animals; Behavior, Animal; Bupropion; Dose-Response Relationship, Drug; Exploratory Behavior; Hippocampus; Locomotion; Male; Microdialysis; Models, Animal; Nicotine; Nicotinic Agonists; Phenotype; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Serotonin; Smoking Cessation | 2009 |
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Brain; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drugs, Investigational; Male; Neurons; Nicotine; Nicotinic Antagonists; Picolines; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Smoking Cessation; Structure-Activity Relationship; Tobacco Use Disorder; Varenicline; Ventral Tegmental Area | 2009 |
The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate.
Topics: Adult; Bupropion; Dopamine Uptake Inhibitors; Follow-Up Studies; Humans; Middle Aged; Nicotine; Prognosis; Pulmonary Disease, Chronic Obstructive; Rehabilitation Centers; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2008 |
Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Comorbidity; Compulsive Behavior; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Prevalence; Regression Analysis; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; United States | 2008 |
Pavlovian drug discrimination with bupropion as a feature positive occasion setter: substitution by methamphetamine and nicotine, but not cocaine.
Topics: Bupropion; Cocaine; Conditioning, Classical; Discrimination Learning; Dopamine Uptake Inhibitors; Humans; Methamphetamine; Nicotine; Peritoneum | 2009 |
Nicotine exposure during adolescence induces a depression-like state in adulthood.
Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Cholinergic Agents; Depression; Emotions; Fluoxetine; Food Preferences; Male; Motor Activity; Nicotine; Rats; Rats, Sprague-Dawley; Reward; Stress, Psychological; Weight Gain | 2009 |
Smoking cessation treatment in a real-life setting: the Greek experience.
Topics: Adult; Bupropion; Counseling; Dopamine Uptake Inhibitors; Female; Greece; Humans; Male; Middle Aged; Nicotine; Smoking Cessation | 2007 |
Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services.
Topics: Administration, Cutaneous; Adult; Benzazepines; Bupropion; Cohort Studies; Community Health Services; Female; Follow-Up Studies; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Participation; Probability; Program Evaluation; Quinoxalines; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome; United Kingdom; Varenicline; Young Adult | 2009 |
An examination of attitudes, knowledge, and clinical practices among Pennsylvania pediatricians regarding breastfeeding and smoking.
Topics: Adult; Attitude of Health Personnel; Breast Feeding; Bupropion; Female; Health Knowledge, Attitudes, Practice; Humans; Infant, Newborn; Male; Middle Aged; Milk, Human; Nicotine; Pediatrics; Pennsylvania; Practice Patterns, Physicians'; Safety; Smoking; Smoking Cessation; Surveys and Questionnaires | 2009 |
Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Behavior Therapy; Breath Tests; Bupropion; Carbon Monoxide; Chi-Square Distribution; Child; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Sleep Wake Disorders; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder | 2009 |
A reader responds to "Seven pharmacotherapies do promote smoking abstinence at 6 and 12 months".
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Benzazepines; Bupropion; Chewing Gum; Female; Follow-Up Studies; Humans; Male; Multivariate Analysis; Nicotine; Nicotinic Agonists; Patient Compliance; Probability; Quebec; Quinoxalines; Risk Assessment; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
[Smoking cessation with special focus on primary health care].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cardiovascular Diseases; Counseling; Evidence-Based Medicine; Family Practice; Humans; Nicotine; Nortriptyline; Outcome Assessment, Health Care; Primary Health Care; Psychotherapy, Group; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Prevention | 2009 |
Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice.
Topics: Animals; Animals, Newborn; Antidepressive Agents; Anxiety; Bupropion; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Male; Maze Learning; Mice; Motor Activity; Nicotine | 2009 |
An investigation of bupropion substitution for the interoceptive stimulus effects of nicotine.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Bupropion; Discrimination Learning; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2010 |
Summaries for patients. Comparison of 3 strategies to quit smoking.
Topics: Administration, Cutaneous; Adult; Bupropion; Combined Modality Therapy; Counseling; Disease Management; Female; Humans; Male; Middle Aged; Nicotine; Primary Health Care; Single-Blind Method; Smoking Cessation; Social Support; Tobacco Use Disorder; Young Adult | 2009 |
Treatment of comorbid tobacco use in people with serious mental illness.
Topics: Adult; Benzazepines; Bupropion; Comorbidity; Counseling; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Schizophrenia, Paranoid; Smoking; Smoking Cessation; Varenicline | 2009 |
What's new in Nicotine & Tobacco Research?
Topics: Advertising; Bupropion; Cardiovascular Diseases; Causality; Comorbidity; Dopamine Uptake Inhibitors; Global Health; Health Knowledge, Attitudes, Practice; Humans; Nicotine; Research Design; Smoking; Smoking Cessation; Tobacco Use Disorder | 2009 |
[Current and future medical drugs for smoking cessation].
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Cannabinoid Receptor Antagonists; Clinical Trials as Topic; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Piperidines; Pyrazoles; Quinoxalines; Rimonabant; Smoking Cessation; Tobacco Use Disorder; Vaccines; Varenicline | 2009 |
Cost-effectiveness of varenicline for smoking cessation.
Topics: Benzazepines; Bupropion; Clinical Trials as Topic; Cost Savings; Cost-Benefit Analysis; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents, Second-Generation; Belgium; Benzazepines; Bupropion; Computer Simulation; Cost-Benefit Analysis; Counseling; Female; Humans; Male; Markov Chains; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Young Adult | 2009 |
Public health clinical demonstration project for smoking cessation in veterans with posttraumatic stress disorder.
Topics: Bupropion; Cohort Studies; Counseling; Delivery of Health Care; Health Promotion; Hotlines; Humans; Internet; Nicotine; Patient Education as Topic; Public Health; Smoking; Smoking Cessation; Smoking Prevention; Stress Disorders, Post-Traumatic; United States; Veterans | 2010 |
Smoking cessation: how to advise the patient.
Topics: Ambulatory Care; Behavior Therapy; Benzazepines; Bupropion; Counseling; Dopamine Uptake Inhibitors; Humans; Motivation; Nicotine; Nicotinic Agonists; Patient Education as Topic; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Smoking Prevention; Varenicline | 2009 |
Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Bupropion; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Mecamylamine; Motivation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Prazosin; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Reward; Time Factors | 2009 |
A comparison of abstinence outcomes among gay/bisexual and heterosexual male smokers in an intensive, non-tailored smoking cessation study.
Topics: Bisexuality; Bupropion; Female; Ganglionic Stimulants; Homosexuality, Female; Homosexuality, Male; Humans; Male; Nicotine; Smoking; Smoking Cessation; Treatment Outcome | 2009 |
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzazepines; Bupropion; Cohort Studies; Dopamine Uptake Inhibitors; Family Practice; Female; Ganglionic Stimulants; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Smoking Cessation; Suicide; Varenicline; Young Adult | 2009 |
The impact of repeated cycles of pharmacotherapy on smoking cessation: a longitudinal cohort study.
Topics: Administration, Cutaneous; Adult; Bupropion; Cohort Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Nicotine; Odds Ratio; Patient Compliance; Probability; Risk Assessment; Smoking Cessation; Smoking Prevention; Treatment Outcome; Young Adult | 2009 |
[Drug treatment of tobacco dependence].
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Humans; Meta-Analysis as Topic; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2009 |
Combined nicotine replacement therapy provides best chance of smoking cessation.
Topics: Administration, Cutaneous; Administration, Oral; Antidepressive Agents, Second-Generation; Bupropion; Drug Therapy, Combination; Humans; Nicotine; Randomized Controlled Trials as Topic; Smoking Cessation; Tobacco Use Disorder | 2010 |
Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials.
Topics: Adolescent; Adult; Black People; Bupropion; Educational Status; Female; Humans; Male; Middle Aged; Nicotine; Racial Groups; Sex Factors; Smoking Cessation; Young Adult | 2010 |
Current treatment options in smoking cessation.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents; Behavior Therapy; Benzazepines; Bupropion; Clonidine; Combined Modality Therapy; Counseling; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Patient Selection; Piperidines; Practice Guidelines as Topic; Pyrazoles; Quinoxalines; Rimonabant; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; United States; Vaccines; Varenicline | 2010 |
Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Analgesics; Animals; Body Temperature; Bupropion; Cell Line; Dopamine Uptake Inhibitors; Humans; Male; Mice; Mice, Inbred ICR; Motor Activity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Nicotinic; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Stereoisomerism; Structure-Activity Relationship | 2010 |
Validation of The Health Improvement Network (THIN) primary care database for monitoring prescriptions for smoking cessation medications.
Topics: Bupropion; Databases, Factual; Dopamine Uptake Inhibitors; England; Humans; Medical Records Systems, Computerized; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Primary Health Care; Smoking Cessation; United Kingdom | 2010 |
Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice.
Topics: Animals; Anxiety; Behavior, Animal; Bupropion; Conditioning, Operant; Discrimination Learning; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Emotions; Hydroxylation; Hyperalgesia; Mice; Mice, Inbred ICR; Nicotine; Nicotinic Agonists; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2010 |
[The management of patients with nicotine dependence - the role of the general practitioners].
Topics: Behavior Therapy; Benzazepines; Bupropion; Combined Modality Therapy; Disease Management; Dopamine Uptake Inhibitors; Family Practice; Humans; Motivation; Nicotine; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Secondary Prevention; Smoking Cessation; Switzerland; Tobacco Use Disorder; Varenicline | 2010 |
[Medical therapy for smoking cessation].
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Antidepressive Agents; Benzazepines; Bupropion; Chewing Gum; Drug Therapy, Combination; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2010 |
Using policy to increase prescribing of smoking cessation medications in the VA healthcare system.
Topics: Bupropion; Dopamine Uptake Inhibitors; Health Policy; Humans; Nicotine; Nicotinic Agonists; Prescriptions; Retrospective Studies; Smoking Cessation; United States; United States Department of Veterans Affairs | 2010 |
Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
Topics: Adult; Aged; Benzazepines; Bupropion; Cohort Studies; Comorbidity; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Stress, Psychological; Treatment Outcome; Varenicline; Young Adult | 2011 |
State medicaid coverage for tobacco-dependence treatments --- United States, 2009.
Topics: Bupropion; Dopamine Uptake Inhibitors; Eligibility Determination; Fee-for-Service Plans; Female; Ganglionic Stimulants; Health Care Surveys; Health Policy; Health Services Accessibility; Healthy People Programs; Humans; Insurance Coverage; Medicaid; Nicotine; Pregnancy; Smoking Cessation; Tobacco Use Disorder; United States | 2010 |
Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.
Topics: Adolescent; Adult; Aged; Australia; Benzazepines; Bupropion; Canada; Cohort Studies; Data Collection; Female; Humans; Male; Medication Adherence; Middle Aged; Nicotine; Nonprescription Drugs; Prescription Drugs; Prevalence; Quinoxalines; Smoking Cessation; Time Factors; Tobacco Use Disorder; Treatment Outcome; United Kingdom; United States; Varenicline; Young Adult | 2011 |
Integrating results from smoking cessation drug research and development into clinical occupational health practice.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Occupational Health Nursing; Practice Guidelines as Topic; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
The effect of five smoking cessation pharmacotherapies on smoking cessation milestones.
Topics: Bupropion; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Nicotine; Nicotinic Agonists; Recurrence; Smoking; Smoking Cessation; Treatment Outcome | 2011 |
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
Topics: Acetylcholine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Azocines; Benzazepines; Bupropion; DNA, Complementary; Dopamine Uptake Inhibitors; Electrophysiological Phenomena; Humans; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oocytes; Pyridinium Compounds; Quinolizines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Varenicline; Xenopus | 2011 |
Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.
Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Biogenic Monoamines; Body Temperature; Bupropion; Conditioning, Psychological; Dopamine; Dopamine Uptake Inhibitors; HEK293 Cells; Humans; Male; Mice; Mice, Inbred ICR; Morpholines; Motor Activity; Nicotine; Nicotinic Antagonists; Norepinephrine; Receptors, Nicotinic; Serotonin; Smoking Cessation; Stereoisomerism; Structure-Activity Relationship | 2011 |
[Comparing the effectiveness of different treatment modalities on the smoking cessation rates].
Topics: Adult; Bupropion; Combined Modality Therapy; Female; Humans; Male; Nicotine; Psychotherapy, Group; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2010 |
[Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Male; Middle Aged; Nicotine; Nicotinic Agonists; Primary Health Care; Quinoxalines; Retrospective Studies; Smoking Cessation; Substance Withdrawal Syndrome; Varenicline; Young Adult | 2011 |
Prescribing of smoking cessation medication in England since the introduction of varenicline.
Topics: Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Humans; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; State Medicine; Time Factors; Varenicline | 2011 |
A real-life study of the effectiveness of different pharmacological approaches to the treatment of smoking cessation: re-discussing the predictors of success.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Bupropion; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Nicotine; Nortriptyline; Retrospective Studies; Sex Factors; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Young Adult | 2011 |
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Nasal Sprays; Nebulizers and Vaporizers; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Time Factors; Transdermal Patch; Treatment Outcome; Varenicline | 2011 |
Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
Topics: Benzazepines; Bupropion; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; England; Epidemiologic Methods; Health Care Costs; Humans; Nicotine; Nicotinic Agonists; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Treatment Outcome; Varenicline; Wales | 2011 |
The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Drug Prescriptions; Electronic Health Records; England; Family Practice; Female; Humans; Male; Middle Aged; Models, Statistical; Nicotine; Nicotinic Agonists; Practice Patterns, Physicians'; Quinoxalines; Smoking; Smoking Cessation; State Medicine; Time Factors; Varenicline; Young Adult | 2011 |
Effects of bupropion on the reinstatement of nicotine-induced conditioned place preference by drug priming in rats.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Bupropion; Conditioning, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Morphine; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar | 2011 |
Smoking cessation pharmacotherapy: a concise overview.
Topics: Adrenergic alpha-2 Receptor Agonists; Antidepressive Agents; Benzazepines; Bupropion; Clonidine; Humans; Nicotine; Nicotinic Agonists; Nortriptyline; Quinoxalines; Smoking; Smoking Cessation; Varenicline | 2011 |
Assessing preferences for improved smoking cessation medications: a discrete choice experiment.
Topics: Adolescent; Adult; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Models, Econometric; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Substance-Related Disorders; Surveys and Questionnaires; Switzerland; Varenicline; Young Adult | 2012 |
Public health clinical demonstration project for smoking cessation in american veterans who served since september 11, 2001.
Topics: Adult; Bupropion; Cohort Studies; Dopamine Uptake Inhibitors; Follow-Up Studies; Health Surveys; Hospitals, Veterans; Humans; Nicotine; Nicotinic Agonists; North Carolina; Patient Acceptance of Health Care; Public Health; Secondary Prevention; Smoking Cessation; Treatment Outcome; Veterans | 2011 |
Breaking free from nicotine dependence. A combination of strategies boosts the odds of success.
Topics: Administration, Cutaneous; Administration, Intranasal; Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Benzazepines; Bupropion; Cognitive Behavioral Therapy; Cross-Sectional Studies; Female; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Self-Help Groups; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2011 |
[Smoking cessation--assistance for the general practitioner].
Topics: Benzazepines; Bupropion; Combined Modality Therapy; Complementary Therapies; Cost-Benefit Analysis; Drug Costs; Fee Schedules; Germany; Humans; Myocardial Infarction; National Health Programs; Nicotine; Nicotinic Agonists; Physician's Role; Polymethacrylic Acids; Polyvinyls; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2011 |
Suicidal behavior and depression in smoking cessation treatments.
Topics: Adult; Benzazepines; Bupropion; Depression; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicide; Varenicline | 2011 |
Memory-related effects of cholinergic receptor ligands in mice as measured by the elevated plus maze test.
Topics: Animals; Bupropion; Dose-Response Relationship, Drug; Ligands; Male; Maze Learning; Memory; Memory Disorders; Mice; Nicotine; Receptors, Cholinergic; Scopolamine | 2011 |
An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Benzazepines; Bupropion; Data Collection; Educational Status; Female; Humans; Internet; Male; Middle Aged; Nicotine; Patient Compliance; Patient Satisfaction; Quinoxalines; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline; Young Adult | 2013 |
Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse.
Topics: Analgesics; Animals; Antidepressive Agents; Body Temperature; Bupropion; Dose-Response Relationship, Drug; Drug Tolerance; Hypothermia, Induced; Male; Mice; Nicotine; Smoking Cessation | 2012 |
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function.
Topics: Animals; Benzazepines; Bupropion; Dopamine Uptake Inhibitors; Electron Transport; Gene Expression; Glucose; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mitochondria; Nicotine; Nicotinic Agonists; Oxidative Stress; Pancreatic Function Tests; Quinoxalines; Rats; Signal Transduction; Smoking; Smoking Cessation; Varenicline | 2012 |
Varenicline and bupropion: suicide.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Patient Safety; Prescription Drug Misuse; Quinoxalines; Risk Assessment; Risk Factors; Smoking Cessation; Suicide; Varenicline | 2012 |
Predictors of success for smoking cessation at the workplace: a longitudinal study.
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Bupropion; Counseling; Dyspnea; Educational Status; Female; Health Care Sector; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Motivational Interviewing; Multivariate Analysis; Nicotine; Nicotinic Agonists; Occupational Health Services; Prognosis; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Switzerland; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome; Workplace; Young Adult | 2014 |
Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6?
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Bupropion; Cytochrome P-450 CYP2A6; Dopamine Uptake Inhibitors; Female; Genetic Association Studies; Genotype; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pharmacogenetics; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Serotonin Plasma Membrane Transport Proteins; Smoking Cessation; Tobacco Use Disorder | 2014 |
Effect of allopurinol on smoking.
Topics: Acetylcholine; Allopurinol; Benzazepines; Brain Chemistry; Bupropion; Causality; Comorbidity; Diabetic Nephropathies; Humans; Hypoxanthine; Molecular Structure; Nicotine; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Structure-Activity Relationship; Varenicline; Xanthine Oxidase | 2013 |
Commentary on Chen et al. (2014): another step on the road to clinical utility of pharmacogenetics for smoking cessation?
Topics: Bupropion; Cytochrome P-450 CYP2A6; Dopamine Uptake Inhibitors; Female; Humans; Male; Nicotine; Smoking; Smoking Cessation | 2014 |
[Safety of nicotine addiction treatment].
Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia | 2013 |
Smoking cessation outcomes among sexual and gender minority and nonminority smokers in extended smoking treatments.
Topics: Adult; Bisexuality; Bupropion; Counseling; Female; Homosexuality, Female; Homosexuality, Male; Humans; Male; Middle Aged; Minority Groups; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Transgender Persons; Treatment Outcome | 2014 |
A comparison of mecamylamine and bupropion effects on memory-related responses induced by nicotine and scopolamine in the novel object recognition test in mice.
Topics: Analysis of Variance; Animals; Bupropion; Cholinergic Agents; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mecamylamine; Memory; Mice; Nicotine; Pattern Recognition, Visual; Scopolamine | 2014 |
Interoceptive conditioning with nicotine using extinction and re-extinction to assess stimulus similarity with bupropion.
Topics: Animals; Bupropion; Conditioning, Psychological; Discrimination, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Radiation; Extinction, Psychological; Male; Nicotine; Nicotinic Agonists; Rats, Sprague-Dawley; Transfer, Psychology | 2014 |
Killing two birds with one stone: the potential role of aripiprazole for patients with comorbid major depressive disorder and nicotine dependence via altering brain activity in the anterior cingulate cortex.
Topics: Antidepressive Agents, Second-Generation; Aripiprazole; Brain; Brain Diseases; Bupropion; Comorbidity; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Gyrus Cinguli; Humans; Nicotine; Serotonin; Smoking; Tobacco Use Disorder; Treatment Outcome | 2014 |
Examination of the effects of varenicline, bupropion, lorcaserin, or naltrexone on responding for conditioned reinforcement in nicotine-exposed rats.
Topics: Animals; Benzazepines; Bupropion; Cholinergic Agents; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Male; Naltrexone; Narcotic Antagonists; Nicotine; Quinoxalines; Rats; Rats, Long-Evans; Reinforcement, Psychology; Varenicline | 2014 |
Nicotine-induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids.
Topics: Acamprosate; Analysis of Variance; Animals; Antidiuretic Hormone Receptor Antagonists; Bupropion; Dose-Response Relationship, Drug; Fructose; Indoles; Male; Motor Activity; Naltrexone; Nicotine; Nicotinic Agonists; Pyrrolidines; Rats, Wistar; Taurine; Tobacco Use Cessation Devices; Topiramate | 2016 |
Bupropion-varenicline interactions and nicotine self-administration behavior in rats.
Topics: Animals; Bupropion; Dose-Response Relationship, Drug; Drug Synergism; Female; Nicotine; Rats; Self Administration; Varenicline | 2015 |
Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Bupropion; Male; Nicotine; Rats; Receptors, Nicotinic; Reward; Self Administration; Smoking Cessation; Tobacco Use Disorder | 2015 |
Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting.
Topics: Adult; Aged; Blood Pressure; Brazil; Bupropion; Cardiovascular Diseases; Comorbidity; Coronary Artery Disease; Diabetes Mellitus; Diastole; Dopamine Uptake Inhibitors; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nicotine; Nicotinic Agonists; Risk Factors; Smoking; Smoking Cessation; Systole; Tobacco Use Cessation Devices; Varenicline | 2016 |
[Varenicline in nicotine replacement therapy: Does it really increase the risk of cardiovascular and neuropsychiatric events?].
Topics: Bupropion; Humans; Nicotine; Nicotinic Agonists; Smoking; Varenicline | 2016 |
Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys.
Topics: Animals; Antidepressive Agents, Second-Generation; Bupropion; Central Nervous System Stimulants; Conditioning, Operant; Discrimination Learning; Dopamine Antagonists; Dose-Response Relationship, Drug; Macaca mulatta; Male; Methamphetamine; Nicotine; Nicotinic Agonists; Reinforcement, Psychology; Risperidone; Time Factors; Varenicline | 2016 |
Commentary on Roberts et al. (2016): Bupropion and varenicline are efficacious and well-tolerated cessation medications for smokers with serious mental illness.
Topics: Benzazepines; Bupropion; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2016 |
Effects of aging on the effectiveness of smoking cessation medication.
Topics: Adult; Age Factors; Aged; Brazil; Bupropion; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Precision Medicine; Smoking Cessation; Treatment Outcome; Varenicline | 2016 |
The use of varenicline to treat nicotine dependence among patients with cancer.
Topics: Adult; Benzazepines; Bupropion; Counseling; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasms; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2017 |
Factors influencing sustainable efficacy of smoking cessation treatment with varenicline beyond nine months.
Topics: Adult; Aged; Aged, 80 and over; Bupropion; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Varenicline | 2016 |
Success of smoking cessation interventions during pregnancy.
Topics: Adolescent; Adult; Bupropion; Dopamine Uptake Inhibitors; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Small for Gestational Age; Longitudinal Studies; Male; Middle Aged; Nicotine; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care; Retrospective Studies; Risk Factors; Smoking Cessation; Tobacco Use Cessation Devices; Young Adult | 2016 |
Sex differences and the role of dopamine receptors in the reward-enhancing effects of nicotine and bupropion.
Topics: Animals; Bupropion; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Female; Male; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward; Sex Characteristics | 2017 |
Using PICO Methodology to Answer Questions About Smoking in COPD Patients.
Topics: Biomarkers; Bupropion; Clinical Trials as Topic; Cost-Benefit Analysis; Counseling; Evidence-Based Medicine; Humans; Motivation; Nicotine; Nicotinic Agonists; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Spirometry; Surveys and Questionnaires; Varenicline | 2017 |
Evaluating the effect of smoking cessation treatment on a complex dynamical system.
Topics: Bupropion; Craving; Drug Therapy, Combination; Fatigue; Humans; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tablets; Tobacco Use Cessation Devices; Treatment Outcome | 2017 |
Smoking cessation treatment outcomes among people with and without mental and substance use disorders: An observational real-world study.
Topics: Adult; Brazil; Bupropion; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Female; Humans; Male; Mental Disorders; Middle Aged; Nicotine; Nortriptyline; Outcome and Process Assessment, Health Care; Psychotherapy, Group; Smoking; Smoking Cessation; Substance-Related Disorders; Treatment Outcome | 2018 |
[Clinical Practice Guidelines for Smoking Cessation].
Topics: Bupropion; Chile; Evidence-Based Medicine; Humans; Nicotine; Smoking Cessation; Varenicline | 2017 |
Beliefs and reality of e-cigarette smoking.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Chills; Depressive Disorder; Electronic Nicotine Delivery Systems; Health Knowledge, Attitudes, Practice; Humans; Male; Nausea; Nicotine; Smoking Cessation; Substance Withdrawal Syndrome; Tachycardia; Tobacco Use Disorder; Vaping | 2018 |
Individual differences in responding to bupropion or varenicline in a preclinical model of nicotine self-administration vary according to individual demand for nicotine.
Topics: Animals; Bupropion; Dose-Response Relationship, Drug; Extinction, Psychological; Individuality; Male; Nicotine; Rats; Reinforcement Schedule; Self Administration; Sucrose; Varenicline | 2019 |
Increasing Smoking Cessation in the United States: Expanding the Availability of Over-the-Counter Medications.
Topics: Behavior Therapy; Bupropion; Humans; Nicotine; Nonprescription Drugs; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; United States; Varenicline | 2019 |
Estimation of high-dimensional propensity scores with multiple exposure levels.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Bupropion; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nicotine; Pharmacoepidemiology; Propensity Score; Proportional Hazards Models; Retrospective Studies; Smoking Cessation; United Kingdom; Varenicline; Young Adult | 2020 |
Effects of chronic treatment with bupropion on self-administration of nicotine + cocaine mixtures in nonhuman primates.
Topics: Animals; Bupropion; Central Nervous System Stimulants; Cocaine; Dose-Response Relationship, Drug; Macaca mulatta; Male; Nicotine; Reinforcement, Psychology; Self Administration; Smoking Cessation Agents | 2020 |
Health-care providers' concern regarding smoking cessation pharmacotherapies during pregnancy: Calls to a teratology information service.
Topics: Australia; Behavior Therapy; Bupropion; Call Centers; Female; Health Personnel; Humans; Information Services; Nicotine; Pregnancy; Smoking; Smoking Cessation; Teratology; Tobacco Use Cessation Devices; Varenicline | 2020 |
Assessment of individual differences in response to acute bupropion or varenicline treatment using a long-access nicotine self-administration model and behavioral economics in female rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Behavior, Animal; Bupropion; Conditioning, Psychological; Economics, Behavioral; Extinction, Psychological; Female; Individuality; Nicotine; Nicotinic Agonists; Rats; Self Administration; Smoking Cessation Agents; Varenicline; Yohimbine | 2020 |
Identification of
Topics: Amisulpride; Animals; Bupropion; Choice Behavior; Conditioning, Classical; Female; Genetic Loci; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mutation; Nicotine; Polymorphism, Single Nucleotide; Receptor, Serotonin, 5-HT1A; Tobacco Smoking; Zebrafish; Zebrafish Proteins | 2020 |
Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study.
Topics: Adult; Bupropion; Crohn Disease; Female; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Pilot Projects; Prevalence; Randomized Controlled Trials as Topic; Severity of Illness Index; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Treatment Outcome; Varenicline | 2020 |
Pregnant Smokers Receiving Opioid Agonist Therapy Have an Elevated Nicotine Metabolite Ratio: A Replication Study.
Topics: Analgesics, Opioid; Bupropion; Cotinine; Female; Humans; Methadone; Nicotine; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation | 2020 |
Sex differences in nicotine-induced impulsivity and its reversal with bupropion in rats.
Topics: Animals; Behavior, Animal; Bupropion; Delay Discounting; Female; Impulsive Behavior; Male; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Sex Characteristics; Sex Factors | 2020 |
Understanding the stimulus effects of nicotine and bupropion in a drug-drug discriminated goal-tracking task.
Topics: Animals; Bupropion; Discrimination Learning; Dose-Response Relationship, Drug; Female; Goals; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley | 2022 |
Bupropion/zonisamide combination to assist smokers to switch from combustible cigarettes to electronic nicotine delivery systems (ENDS).
Topics: Adult; Bupropion; Electronic Nicotine Delivery Systems; Humans; Nicotine; Smokers; Substance Withdrawal Syndrome; Tobacco Products; Zonisamide | 2022 |
Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
Topics: Aged; Australia; Benzazepines; Bupropion; Humans; Male; Nicotine; Nicotinic Agonists; Quinoxalines; Retrospective Studies; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
[Tobacco cessation treatment for people with schizophrenia].
Topics: Benzazepines; Bupropion; Humans; Nicotine; Quinoxalines; Schizophrenia; Smoking Cessation; Tobacco Use Cessation; Tobacco Use Cessation Devices; Varenicline | 2022 |
Publicly subsidised smoking cessation medicines in times of COVID-19 in Australia: An interrupted time series analysis.
Topics: Bupropion; COVID-19; Humans; Interrupted Time Series Analysis; Nicotine; Nicotinic Agonists; Pandemics; Pharmaceutical Preparations; Smoking; Smoking Cessation; Tobacco Use Cessation Devices; Varenicline | 2023 |
Varenicline serves as the training stimulus in the drug-discriminated goal-tracking task with rats: initial evaluation of potential neuropharmacological processes.
Topics: Animals; Benzazepines; Bupropion; Goals; Motivation; Nicotine; Nicotinic Agonists; Quinoxalines; Rats; Receptors, Nicotinic; Smoking Cessation Agents; Varenicline | 2023 |
[Smoking, heated tobacco products, alcohol and diabetes mellitus (update 2023)].
Topics: Benzazepines; Bupropion; Diabetes Mellitus; Electronic Nicotine Delivery Systems; Ethanol; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Tobacco Products; Tobacco Use Cessation Devices | 2023 |